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Resumo 
 No sistema nervoso central, a maior parte da neurotransmissão excitatória é 
mediada por receptores de glutamato do tipo AMPA que possuem papéis fundamentais 
na plasticidade sináptica, o fenómeno celular na base de processos de aprendizagem e 
memória. Modificações no tráfego destes receptores e na sua inserção ao nível das 
sinapses, bem como na estabilidade do RNA mensageiro das subunidades dos 
receptores ou no seu decaimento, são cruciais para induzir alterações de longo prazo na 
força e eficiência sinápticas, o que permite a expressão de mecanismos de plasticidade. 
Tendo isto em conta, torna-se particularmente importante compreender a fundo como é 
que estes eventos são regulados, de forma a desvendar os mecanismos que estão na base 
de várias formas de plasticidade.  
 Um estudo recente realizado no nosso laboratório permitiu a identificação da 
proteína 1 associada à Contactina (Caspr1) como um novo interactor da subunidade 
GluA1 dos receptores AMPA. Esta proteína foi capaz de induzir um aumento nos níveis 
superficiais de GluA1, bem como mediar o seu endereçamento para a membrana 
sináptica. Para além disso, e duma maneira independente da transcrição, a Caspr1 foi 
capaz de induzir um aumento nos níveis de RNAm de GluA1, o que sugere um papel 
importante da Caspr1 na regulação da estabilidade destes transcriptos. Estas evidências 
propõem então a existência de um novo mecanismo de regulação pós-transcripcional 
dos receptores AMPA, desconhecido até agora. Ainda assim, o papel da Caspr1 na 
regulação da subunidade GluA1 está longe de ser compreendido, pelo que é importante 
continuar a caracterizar este mecanismo regulador.   
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 Neste trabalho procurámos, em primeiro lugar, confirmar o papel da Caspr1 na 
regulação da subunidade GluA1. A sobreexpressão da Caspr1, tanto num sistema 
heterólogo como em neurónios primários de hipocampo, resultou num aumento 
significativo nos níveis totais de GluA1. Para além disso, conseguimos identificar o 
domínio intracelular da Caspr1 rico em prolinas como sendo o responsável por estes 
efeitos nos níveis de GluA1. De facto, uma forma da Caspr1 sem o domínio rico em 
prolinas não teve qualquer efeito nos níveis totais de GluA1, em células COS7.   
 Tendo em conta que o domínio rico em prolinas da Caspr1 é capaz de interagir 
com domínios SH3 de várias moléculas de sinalização, em particular com a tirosina 
cínase Src, colocámos a hipótese de o efeito da Caspr1 nos níveis de GluA1 ocorrer por 
activação, mediada pelo seu domínio de prolinas, de uma via de sinalização a jusante da 
Src. De facto, a expressão da Caspr1 em células COS7 foi capaz de induzir um grande 
aumento nos níveis de Src fosforilada, bem como nos níveis de ZBP1 (proteína 1 de 
ligação a ‘zipcodes’) fosforilada. Este alvo de fosforilação pela Src é uma proteína de 
ligação a RNAs, conhecida por regular a tradução de vários RNAm. Para além disso, a 
sobreexpressão da Caspr1 em neurónios de hipocampo induziu um aumento 
significativo e específico no número de agregados de Src e ZBP1 fosforiladas, ao nível 
da sinapse.  
 Por fim, tentámos investigar quais os estímulos fisiológicos capazes de regular a 
expressão endógena da Caspr1. Um pormenor interessante é que o efeito que a Caspr1 
exerce sobre os níveis da subunidade GluA1 assemelha-se bastante ao efeito induzido 
por um bloqueio crónico da actividade neuronal, bloqueio esse que induz um fenómeno 
de plasticidade homeostática que depende do aumento da expressão de receptores 
AMPA, numa tentativa de restituir os níveis de actividade neuronal. De acordo com 
xv 
 
 
 
isto, um bloqueio crónico da actividade neuronal induzido por TTX (bloqueador 
específico de canais de sódio dependentes de voltagem), foi capaz de promover um 
aumento significativo, não só nos níveis totais de GluA1, mas também nos níveis 
endógenos da Caspr1. Além disso, esta manipulação da actividade neuronal foi ainda 
capaz de induzir a activação da via de sinalização da Src, aumentando os níveis de Src e 
ZBP1 fosforiladas.  
 Em conclusão, este estudo contribuiu para caracterizar os mecanismos 
moleculares envolvidos na sobrerregulação da subunidade GluA1 pela Caspr1, bem 
como para identificar estímulos fisiológicos com impacto nestes mecanismos. Por fim, 
este estudo propõe um papel promissor para a Caspr1 na regulação de mecanismos na 
base da plasticidade homeostática.   
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Abstract 
 Fast excitatory synaptic transmission in the central nervous system is mediated 
by glutamate receptors of the AMPA-type, which play key roles in synaptic plasticity, 
the cellular correlate of learning and memory. Modulating the traffic and synaptic 
insertion of these receptors as well as their protein levels, e.g. through regulation of 
their mRNA stability and turnover, is crucial to induce long-term changes in synaptic 
strength and efficacy, which accounts for the expression of mechanisms of synaptic 
plasticity. Thus, understanding how these events are regulated is of major importance to 
fully unravel the mechanisms that underlie several forms of plasticity. 
 Recent data from our laboratory identified the integral membrane protein 
Contactin associated protein 1 (Caspr1) as a novel interactor of the GluA1 subunit of 
AMPARs. This protein was able to increase the cell surface expression of GluA1 and 
also, mediate its traffic to the synaptic membrane. Moreover, Caspr1 presented an 
upregulatory effect in GluA1 mRNA levels, in a transcription-independent manner, 
which suggests a role for Caspr1 in the regulation of GluA1 mRNA stability. These 
evidences suggest a novel post-transcriptional regulatory mechanism of AMPARs, 
unknown until now. Thus, it became important to further characterize the regulation of 
the GluA1 AMPAR subunit by Caspr1. 
 We firstly sought to confirm the role of Caspr1 in regulating the protein levels 
for the GluA1 subunit. Overexpression of Caspr1, both in a heterologous system and in 
cultured hippocampal neurons, resulted in a significant increase in the total levels of 
GluA1. Moreover, we identified the proline-rich region of Caspr1 as the molecular 
determinant responsible for its effect in GluA1 levels. Indeed, when expressing a 
xviii 
 
 
 
construct specifically deleted for the proline-rich domain, Caspr1 failed to increase 
GluA1 total levels, in COS7 cells. 
Taking into account that the proline-rich domain of Caspr1 interacts with SH3 
domains of various signaling molecules, particularly that of the tyrosine kinase Src, we 
hypothesized that the effect of Caspr1 in GluA1 levels occurs through a proline domain-
mediated activation of a signaling pathway downstream of Src. Expression of Caspr1 in 
COS7 cells resulted in a marked increase in levels of phosphorylated Src as well as 
phosphorylated levels of its downstream target, Zipcode binding protein 1 (ZBP1), a 
RNA-binding protein known to regulate mRNA translation upon Src-dependent 
phosphorylation. Moreover, overexpression of Caspr1 in hippocampal neurons was able 
to induce a specific increase in the number of both phosphorylated Src and ZBP1 puncta 
at the synaptic level. 
 Furthermore, we sought to investigate physiological stimuli capable of 
regulating the endogenous expression of Caspr1. Interestingly, the upregulatory effect 
that Caspr1 exerts in levels of GluA1 subunit parallels that of chronically blocking 
neuronal activity, which results in a homeostatic synaptic scaling of GluA1. 
Accordingly, chronic blockade of activity induced by TTX, a blocker of voltage-gated 
sodium channels, was able to significantly increase not only GluA1 total levels, but also 
levels of endogenous Caspr1. Moreover, this manipulation of neuronal activity was able 
to induce an activation of the Src signaling pathway, with increases in phosphorylated 
levels of both Src and ZBP1.  
 In conclusion, this study contributed to characterize the molecular mechanisms 
involved in the upregulation of the GluA1 subunit by Caspr1, as well as the 
xix 
 
xix 
 
physiological stimuli that impinge on those mechanisms. Moreover, it unveils a 
potentially promising role for Caspr1 in mediating homeostatic plasticity mechanisms.  
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3 
The Glutamatergic Synapse 
  Most of the excitatory neurotransmission in the Central Nervous System (CNS) 
is mediated by the amino acid glutamate. After release from the presynaptic nerve 
terminal, glutamate binds to specific receptors on the postsynaptic membrane to conduct 
excitatory transmission. The effects of glutamate are mediated through its action on two 
distinct categories of glutamate receptors: metabotropic receptors and ionotropic 
receptors, which differ in their molecular, biochemical, pharmacological and 
physiological properties (Hollmann & Heinemann, 1994; Kew & Kemp, 2005; Santos et 
al., 2009).  
Metabotropic glutamate receptors are coupled to G proteins and their activation 
generates intracellular secondary messengers. Ionotropic glutamate receptors, on the 
other hand, form cation channels that open upon receptor activation by their specific 
agonists (Carvalho et al., 2000). Ionotropic glutamate receptors exhibit great diversity 
and have been divided into three broad subtypes, according to their electrophysiological 
properties and most selective agonists: alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) receptors 
(Carvalho et al., 2000; Watkins, 1981). Upon binding of synaptically released glutamate 
to the ionotropic receptors, a depolarization of the postsynaptic membrane is produced; 
nevertheless, these different types of glutamate receptors, particularly AMPA and 
NMDA, have very diverse roles in synaptic function (Carvalho et al., 2000; Hollmann 
& Heinemann, 1994). AMPA receptors mediate the majority of fast excitatory currents 
in glutamate-mediated neurotransmission in conditions of basal neuronal activity, and 
thus, have a great influence in the strength of the synaptic response (Esteban, 2003; 
Ozawa et al., 1998). On the other hand, NMDA receptors, at resting membrane 
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potential, remain silent with a voltage-dependent magnesium blockade. Nonetheless, 
their activation and subsequent calcium influx are critical for the induction of specific 
forms of synaptic plasticity, such as long-term potentiation (LTP) and long-term 
depression (LTD) (Bear & Malenka, 1994; Esteban, 2003; Gomes et al., 2003; Malenka 
& Nicoll, 1999).  
 
AMPA Receptors 
 AMPA receptors are responsible for the primary depolarization in glutamatergic 
neurotransmission and are thought to play key roles in synaptic plasticity. Long-lasting 
and activity-dependent changes in synaptic strength and efficacy are associated with 
modifications in traffic and cellular distribution of AMPAR, post-translational and post-
transcriptional modifications of AMPAR subunits, and are thought to underlie learning 
and memory formation (Morris, 2006; Rumpel et al., 2005; Whitlock et al., 2006). 
 
Expression of AMPA Receptors 
 AMPA receptors are composed of four homologous subunits, GluA1 – GluA4 
(Hollmann & Heinemann, 1994) encoded by four closely related genes, with about 70% 
sequence homology (Collingridge et al., 2004). They comprise about 900 amino acids, 
have a molecular weight of about 105kDa and assemble in tetramers in different 
stoichiometries to form AMPA receptors with different properties (Figure 1A) 
(desensitization/resensitization kinetics and conductance properties) (Ozawa et al., 
1998; Rosenmund et al., 1998; Santos et al., 2009). Several studies using in situ 
hybridization, receptor autoradiography and immunocytochemistry [reviewed in 
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5 
(Hollmann & Heinemann, 1994)] reveal a widespread distribution of AMPA receptors 
throughout the brain, which is in conformity with their key role in excitatory 
neurotransmission (Santos et al., 2009). While GluA1-GluA3 subunits are particularly 
enriched in the outer layers of the cerebral cortex, hippocampus and amygdala 
(Keinanen et al., 1990), the GluA4 subunit is present in lower amounts throughout the 
CNS, except in the cerebellum, where this subunit is also abundant (Petralia & 
Wenthold, 1992). Interestingly, in the hippocampus, the expression of AMPAR subunits 
is also differentially regulated during development: in the mature hippocampus, 
AMPARs are mainly composed of GluA1 – GluA2 or GluA2 – GluA3 combinations 
(Wenthold et al., 1996), whereas GluA4-containing AMPARs are primarily expressed 
in early postnatal development (Esteban, 2003; Zhu et al., 2000).   
 
 
Figure 1 – Topology of AMPAR subunits and their assembly. (A) Membrane topology of the 
AMPAR subunit and schematic representation of the tetrameric channel. Each individual 
subunit is composed of an extracellular N-terminal, a ligand binding domain, four 
transmembrane domains that comprise the ionic channel of the receptor and a final highly 
variable intracellular C-terminal. The individual subunits assemble to form a heterotetrameric 
channel. Roles of each domain and the proposed mechanism of assembly are described in the 
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text. [Adapted from (Shepherd & Huganir, 2007)] (B) Structure of the full-length 
homotetrameric rat GluA2 receptor at 3.6Å obtained by X-ray crystallography [Adapted from 
(Sobolevsky et al., 2009)]. 
 
AMPA receptor structure and diversity 
 AMPA receptors were initially predicted to assemble in a tetrameric 
stoichiometry for functional receptors, with a large extracellular N-terminal region 
followed by a membrane-spanning domain. The pore of the receptor appeared to be 
formed by a re-entrant hairpin loop within the transmembrane region, finally followed 
by a cytoplasmic C-tail (Bredt & Nicoll, 2003). Despite this plausible prediction, 
insights into the mechanism by which glutamate binding regulates AMPA receptor 
channel gating were not uncovered until 2009, when Gouaux and collaborators 
determined an accurate, atomic resolution description of AMPA receptor architecture 
and a definition of the arrangement of its subunits based on crystallographic studies 
(Figure 1B) (Sobolevsky et al., 2009). Accordingly, AMPA subunits do indeed form 
functional homotetramers, although native receptors are almost exclusively 
heterotetramers. Each subunit has a modular composition that includes a large first 
extracellular amino terminal domain (ATD) that participates in subtype-specific 
receptor assembly, trafficking and modulation (Madden, 2002); followed by an adjacent 
ligand-binding domain (LBD) that is split into two segments, S1 and S2, whose 
structure had previously been determined by Gouaux and associates (Armstrong et al., 
1998). These segments show homology to the glutamine binding protein (QBP), which 
suggests a binding site for glutamate, granting the LBD a central role for agonist / 
competitive antagonist binding and to activation gating (Sobolevsky et al., 2009). Next 
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7 
comes the transmembrane domain (TMD) that, with the second hydrophobic hairpin 
loop, forms the membrane-spanning ion channel; and a final cytoplasmic carboxyl-
terminal, the most structurally and functionally divergent region among subunits, which 
contains regulatory domains targeted by multiple intracellular signal transduction 
pathways and that mediate the involvement of the C-terminal in receptor localization 
and regulation (Figure 1) (Derkach et al., 2007; Sobolevsky et al., 2009).  
 In addition to the subunit stoichiometry, AMPAR function is further diversified 
by RNA processing events, including alternative splicing and RNA editing (Dingledine 
et al., 1999). In the adult brain, particularly at the mature hippocampal excitatory 
synapses, AMPARs consist predominantly of GluA1 – GluA2 or GluA2 – GluA3 
subunits. Most mature GluA2 proteins contain an arginine residue (R) within the re-
entrant TM2 membrane loop region at position 586 in place of the genomically-encoded 
glutamine (Q) (Santos et al., 2009; Sommer et al., 1991). This Q/R discrepancy is 
explained by post-transcriptional mRNA editing and it occurs in more than 99% of 
GluA2 mRNA transcripts. The Q/R site controls various AMPAR properties including 
Ca2+ permeability, channel conductance, subunit assembly into functional receptors as 
well as endoplasmic reticulum (ER) export kinetics. Thus, GluA2-lacking receptors 
have a high Ca2+ permeability, channel conductance, open probability and rectification, 
that is, only allow ion flow into the cell, as opposed to GluA2-containing receptors that 
lack rectification and exhibit low channel conductance and open probability and are 
highly impermeable to Ca2+ (Bowie et al., 1998; Derkach et al., 2007; Geiger et al., 
1995; Greger et al., 2003). Hence, the presence or absence of the GluA2 subunit in 
AMPARs can dramatically alter their properties and, consequently, synaptic 
transmission. 
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Another structural mechanism that determines channel properties is alternative 
splicing. Within the LBD, particularly at the C-terminal part of the S2 region, two 
mutually exclusive exons termed flip and flop can be expressed due to alternative RNA 
splicing. These two alternative exons are present in all four subunits and differ in a few 
amino acids only; nevertheless, their alternative splicing results in AMPARs with 
different desensitization and ER export kinetics (Santos et al., 2009). Thus, the 
composition of subunits, post-transcriptional modifications, and especially RNA 
editing, endow AMPARs with substantial diversity and also determine the ion channel 
characteristics of the receptor (Jiang et al., 2006). 
 
Post-translational modifications of AMPA receptors 
Properties and function of AMPARs may also be modulated by post-
translational modifications such as glycosylation, palmitoylation and phosphorylation. 
Glycosylation is a protective modification that can occur at 4-6 different sites located in 
the extracellular domains of each AMPAR subunit. This N-glycosylation may facilitate 
the maturation of AMPARs and protect them from proteolytic degradation (Everts et 
al., 1997; Jiang et al., 2006). Palmitoylation is a reversible fatty acetylation that 
regulates protein trafficking and cellular localization. All AMPAR subunits can be 
palmitoylated on two cysteine residues in their transmembrane domain TM2 and in their 
intracellular C-terminal region. The first palmitoylation in TM2 leads to an 
accumulation of AMPAR in the Golgi apparatus, resulting in a decreased expression of 
the receptor in the cell surface. On the other hand, palmitoylation at the C-terminal 
domain contributes to receptor internalization by disrupting its interaction with the 4.1N 
protein, known to stabilize AMPAR expression on the surface (Hayashi et al., 2005). 
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Up until today, four phosphorylation sites have been reported for the GluA1 
subunit (Figure 2) (Lee et al., 2010), all residing in the intracellular C-terminal of 
GluA1. The first identified site was a serine residue 831 (S831) prone to be 
phosphorylated by protein kinase C (PKC) (Roche et al., 1996) and calcium-
calmodulin-dependent protein kinase (CaMKII) (Mammen et al., 1997). Also, Serine 
845 (S845) was identified as a protein kinase A (PKA) phosphorylation substrate 
(Roche et al., 1996). Serine 818 (S818) was only later discovered to be a PKC substrate 
(Boehm et al., 2006) and only just recently Threonine 840 (T840) was found to be a 
major regulatory phosphorylation site of PKC in GluA1 (Figure 2) (Lee et al., 2007). 
Phosphorylation of these residues is thought to be important for regulating the GluA1-
containing AMPAR trafficking and synaptic insertion, and plays a role in two 
prototypic forms of synaptic plasticity: hippocampal NMDA-dependent Long-term 
Potentiation (LTP) and Depression (LTD). These plastic synaptic events, LTP and LTD, 
are associated with phosphorylation and dephosphorylation, respectively, of distinct 
GluA1 phosphorylation sites (Carvalho et al., 2000; Jiang et al., 2006; Lee et al., 2000; 
Lee et al., 2010). 
The GluA2 subunit is also phosphorylated at two major sites (Figure 2). Serine 
880 (S880) is the phosphorylation site for PKC located in the extreme C-terminal 
sequence within the PDZ (postsynaptic density 95/ disc large / zonula occludens-1) 
domain binding site, through which GluA2 binds to different proteins, namely the 
glutamate receptor interacting protein / AMPAR binding protein (GRIP/ABP) and the 
protein interacting with C-kinase-1 (PICK1). The other phosphorylation site, a tyrosine 
residue (Y876) in the GluA2 C-terminus, is a substrate for the Src family of protein 
tyrosine kinases that renders a similar effect as the phosphorylation in S880 (Hayashi & 
Huganir, 2004). Thus, phosphorylation at GluA2 plays a role in the differential binding 
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of GluA2 to interacting PDZ domain-containg proteins and is a critical means to 
regulate receptor trafficking (Gomes et al., 2003). GluA2 phosphorylation at this region 
disrupts receptor binding to GRIP, recruits PICK1 to excitatory synapses and promotes 
a rapid internalization of surface receptors, which is a critical event for the induction of 
LTD (Chung et al., 2003; Chung et al., 2000; Matsuda et al., 1999). 
 
AMPA receptor biosynthesis 
 The biogenesis of oligomeric transmembrane proteins occurs at the ER 
membrane and commences with the co-translational insertion of nascent polypeptides in 
this organelle. AMPARs are modular polypeptides, divided into four distinct domains 
that engage in intersubunit interactions during assembly (Greger & Esteban, 2007; 
Greger et al., 2007). Messages for AMPARs, just as for other oligomeric 
transmembrane proteins, are translated on the rough ER, and transit through the ER 
represents the first site for receptor assembly and regulation. In analogy to K+ channels, 
AMPAR are thought to assemble as dimers of dimers (Madden, 2002; Tu & Deutsch, 
1999). Within the ER, mechanisms that determine the combination of oligomers are not 
well understood but seem to depend on interactions between the luminal, N-terminal 
domains of the subunits that mainly mediate the initial dimer formation (Esteban, 2003; 
Greger et al., 2007). This tight interaction constitutes a compatibility determinant, 
ensuring association between subunits of only a given GluR family (Greger & Esteban, 
2007). The subsequent assembly step, tetramerization, involves the extracellular S2 loop 
and the transmembrane segments and appear to be guided by contacts within LBD 
dimers, generating the fourfold symmetry ion channel (Greger & Esteban, 2007; Greger 
et al., 2007).  
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Following their synthesis in the ER, the assembled AMPARs transit to the Golgi 
apparatus and are trafficked by microtubule-based machinery either to dendrites or to 
axons, where they are inserted in membranes (Bredt & Nicoll, 2003). Nevertheless, 
tetramerization by itself does not seem to provide AMPARs with the ability to be 
exported from the ER. Interestingly, it has been suggested that binding of glutamate to 
the receptor within the ER may be required for ER exit by promoting the stabilization of 
different conformation states during folding and assembly (Fleck, 2006). Moreover, 
these conformational transition states appear to facilitate the co-assembly of AMPARs 
with auxiliary subunits or transport factors. The AMPAR-auxiliary subunit stargazin 
and its relatives, the transmembrane AMPAR regulatory proteins (TARPs), seem to be 
required for early secretory trafficking; also, they interact with the LBD, slowing gating 
kinetics and recognizing specific conformational states of this domain. Thus, they may 
contribute to render AMPAR competent for ER export (Tomita et al., 2005b; Ziff, 
2007). This may imply that the exit from the ER is under stringent quality control and 
that the efficiency of these processes impacts on ER export kinetics, determining the 
number of receptors available for expression at synapses  (Greger & Esteban, 2007; 
Greger et al., 2007).  
 
AMPA receptor trafficking mechanisms 
To ensure a correct neuronal communication, that requires the modulation of the 
excitatory neurotransmission, the presence of AMPARs at synapses has to be carefully 
regulated. Interestingly, these receptors are not static components of the synaptic 
membrane. On the contrary, they are continuously being delivered and removed in and 
out of the synapse in response to neuronal activity. Most AMPARs are likely to be 
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synthesized in the neuronal cell body, away from synapse. Therefore, newly synthesized 
receptors have to undergo a series of trafficking steps before being delivered to the 
synapse. This trafficking involves an intricate network of protein – protein interactions 
that, after the synthesis of receptors in the ER and transit through the Golgi apparatus, 
allows their transport along dendrites, ending with their local insertion and removal 
from synapses (Esteban, 2003). 
 
AMPA receptor interaction partners  
Unquestionably, the localization and trafficking of AMPARs are both extremely 
complicated and highly regulated processes. Because AMPARs themselves lack motor 
domains, they must associate with many protein partners that assist in their trafficking 
(Bredt & Nicoll, 2003; Henley, 2003; Jiang et al., 2006). Indeed, accessory and 
scaffolding proteins interact with AMPARs at numerous subcellular domains. 
Particularly, the C-terminus of AMPARs, the most structurally and functionally 
divergent region among subunits, has been extensively investigated, mainly using yeast 
two-hybrid and GST pull-down assays, in the search for these interacting proteins 
(Figure 2). The large collection, almost certainly still incomplete, of AMPAR partners 
identified and characterized until today has begun to explain the details of AMPAR 
trafficking and surface expression and has given an insight on the roles of individual 
interactors in these mechanisms (Bredt & Nicoll, 2003; Henley, 2003). 
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Figure 2 – Sequence alignment of the intracellular C-terminal region of the different 
AMPAR subunits. The different phosphorylation sites for each subunit and the various binding 
sites for interacting proteins are underlined and highlighted in red or with boxes, respectively. In 
the picture, the former nomenclature is used for the different subunits of AMPARs: GluR1, 
GluR2, GluR2L, GluR3, GluR4 and GluR4c correspond, respectively, to GluA1, GluA2, 
GluA2L, GluA3, GluA4 and GluA4c, in the new nomenclature (Santos et al., 2009). 
 
AMPA receptor subunit-specific interactions 
AMPA receptor insertion in the synaptic membrane involves tightly regulated 
events that depend on the subunit composition of the receptor and on specific signals 
contained within the C-termini. Major insight into mechanisms that regulate trafficking 
of AMPARs came from the discovery that proteins containing PDZ domains play 
general roles in scaffolding membrane proteins (Bredt & Nicoll, 2003; Henley, 2003). 
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PDZ domains are modular protein – protein interaction motifs that contain three repeats 
of approximately 90 amino acids and are present in well over 100 otherwise unrelated 
proteins (Ponting et al., 1997; Songyang et al., 1997). Most of the interactions mediated 
by PDZ domains occur via the recognition of a short motif located at the extreme C-
terminus of the binding protein, promoting both the clustering of ion channels and 
receptors at the plasma membrane, as well as the targeting of kinases and phosphatases 
towards their substrates (Garner et al., 2000; Henley, 2003; Sheng & Sala, 2001). 
Synapse-associated protein 97 (SAP97) was the first protein reported to directly 
interact with the GluA1 subunit (Figure 2). SAP97 has three PDZ domains and interacts 
with GluA1 C-terminal in its second PDZ domain (Leonard et al., 1998). SAP97 highly 
accumulates at GluA1-containing synapses, which suggested that SAP97 could act as an 
anchoring molecule to help GluA1 reside stably in the synaptic surface (Valtschanoff et 
al., 2000). The interaction between SAP97 and GluA1 first occurs in the receptor 
secretory pathway and is essential for the transport of the receptor from the ER to the cis 
face of the Golgi apparatus, with SAP97 dissociating from the complex at the plasma 
membrane (Sans et al., 2001; Santos et al., 2009). SAP97 was also reported to be 
important for the recruitment of PKA and PKC through the A Kinase Anchoring Protein 
79 (AKAP79), which forms a complex that targets PKA to GluA1, facilitating its S845 
phosphorylation (Colledge et al., 2000; Jiang et al., 2006).  
Protein 4.1N is another GluA1-interacting protein that belongs to a family of 
multifunctional cytoskeleton components and that is essential for assembly and 
maintenance of the actin cytoskeleton. Protein 4.1N is highly expressed in excitatory 
synapses, where it interacts and binds to the intracellular membrane region of GluA1, 
colocalizing with AMPARs. Thus, 4.1N may serve as an adapter to link GluA1 to the 
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actin cytoskeleton in spines, which suggests that GluA1-containing AMPARs are 
delivered to synapses along actin filaments (Jiang et al., 2006; Shen et al., 2000). 
PDZ proteins also interact with the C terminus of GluA2, which conforms to a 
type II PDZ binding site, as opposed to GluA1 that conforms to a type I PDZ ligand. 
Yeast two-hybrid screening with the C-terminal tail of GluA2 yielded two highly 
related proteins, previously mentioned, GRIP and ABP, both containing seven 
consecutive PDZ domains (Bredt & Nicoll, 2003; Dong et al., 1997).  Both proteins 
localize at synapses but also in post-Golgi vesicles, suggesting a possible role in 
AMPAR trafficking to dendrites. Mutations of the GluA2 PDZ binding site that 
selectively block its binding to ABP and GRIP accelerate GluA2 endocytosis at 
synapses (Osten et al., 2000), identifying ABP and GRIP as anchors that are crucial to 
AMPARs synaptic accumulation but not to their synaptic targeting (Santos et al., 2009). 
The C termini of GluA2/3 also associate with the PDZ domain of PICK1, a postsynaptic 
scaffold (Xia et al., 1999). This protein was first described to interact with the catalytic 
domain of PKCα, and it has been proposed that dimeric PICK1 can act to chaperone 
activated PKC and AMPARs (Chung et al., 2000). Several studies indicate that PICK1 
regulates the surface expression of GluA2 (Terashima et al., 2004), and it has recently 
been shown that the phosphorylation state of GluA2 S880, mediated by PKC, which 
promotes the binding of PICK1 to GluA2, regulates the rate of GluA2 recycling to the 
membrane (Lin & Huganir, 2007; Santos et al., 2009). 
 
AMPA receptor transmembrane interactors  
AMPARs contain transmembrane AMPAR regulatory proteins (TARPs) as their 
auxiliary subunits (Ziff, 2007). These proteins are subdivided in two classes: class I that 
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comprises γ-2 (or stargazin), γ-3, γ-4 and γ-8, and γ-5 and γ-7 as class II (Sumioka et 
al., 2010). Stargazin, the prototypical TARP, was the first identified auxiliary subunit of 
AMPARs and it was originally characterized as the mutant gene in the Stargazer mouse, 
which exhibits an ataxic and epileptic phenotype, resulting from the lack of functional 
AMPAR channels in cerebellar granule cells (Chen et al., 2000; Osten & Stern-Bach, 
2006). These proteins contain four transmembrane domains and their carboxyl terminus 
interacts with the PDZ domains of PSD-95 (Chen et al., 2000). TARPs appear to 
coassemble with AMPARs early in the synthetic pathway and control their folding, 
assembly and maturation, stabilizing and facilitating their export from the ER. 
Furthermore, TARPs promote AMPAR surface expression and are critical for clustering 
AMPARs at excitatory synapses through their interaction with PSD-95 (Chen et al., 
2000; Santos et al., 2009; Sumioka et al., 2010; Tomita et al., 2003).  
In a recent study, another family of transmembrane proteins, the cornichon 
proteins, was found to interact with AMPARs subunits (Schwenk et al., 2009). 
According to this study, the majority of AMPARs in the rat brain are coassembled with 
two members of the cornichon family of transmembrane proteins (cornichon homologs 
2 and 3), rather than with the TARPs. Cornichons increase surface expression of 
AMPARs in cultured cells and Xenopus oocytes. Moreover, electrophysiology 
recording from Xenopus oocytes showed that these proteins alter channel gating by 
markedly slowing deactivation and desensitization kinetics. 
 
Vesicular / Cytoskeletal trafficking of AMPA receptors 
Neurons pose many unique problems for the trafficking of membrane proteins 
because of their highly polarized and elaborate structure. Membrane proteins must 
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travel extremely long distances, and transmembrane proteins may be inserted at plasma 
membrane domains far from their final location (Shepherd & Huganir, 2007). Early in 
development, packets of receptors and scaffolding proteins travel along dendrites 
(Gerrow et al., 2006). However, the precise cues that determine where these receptors 
stop and form synapses are not fully understood so far. Moreover, due to the primary 
localization of AMPAR mRNA at the neuronal cell body, the long-range dendritic 
transport of AMPARs is likely to depend on the microtubular cytoskeleton that runs 
along dendritic shafts (Esteban, 2003; Groc & Choquet, 2006). The transport of 
membrane organelles on microtubule tracks is an active process that relies on the motor 
proteins of the kinesin and dynein superfamilies (Hirokawa & Takemura, 2005). The 
PDZ domain-containing protein GRIP / ABP, besides binding to the C-terminal PDZ 
binding motif of GluA2 and GluA3, interacts directly with the heavy chain of 
conventional kinesin (KIF5), suggesting that GRIP may also serve as the link between 
AMPARs and microtubular motor proteins (Esteban, 2003; Setou et al., 2002; Shepherd 
& Huganir, 2007).  
Although dendrites contain microtubules along which most cargo is transported, 
dendrites also contain actin. Particularly, dendritic spines are devoid of microtubular 
cytoskeleton, but enriched of highly motile actin filaments (Fischer et al., 1998). 
Therefore, at some point, AMPAR-containing organelles, trafficking along microtubular 
tracks, must be transferred to the actin-based cytoskeleton for their final delivery at 
synapses (Esteban, 2003). Myosins, the main actin-dependent motor proteins, have 
recently been implicated in AMPAR transport. Myosin Vb has been associated with 
GluA1 and the expression of the myosin Vb tail domain in developing hippocampal 
neurons enhances the accumulation of GluA1 in the soma, reducing the surface 
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expression of this subunit (Lisé et al., 2006). Myosin VI has also been implicated in 
AMPAR trafficking, since myosin VI-deficient neurons exhibit deficits in activity-
dependent AMPAR internalization as well as a decrease in the number of synapses and 
dendritic spines (Shepherd & Huganir, 2007). Also, protein 4.1N may act as an actin 
adaptor between AMPARs and the actin cytoskeleton, since it was shown to associate 
with AMPARs and stabilize the surface expression of GluA1 (Shen et al., 2000; 
Shepherd & Huganir, 2007). 
 
Exocytosis 
AMPARs localization is a highly dynamic process, with AMPARs cycling in 
and out of synapses under a variety of situations related to synaptic plasticity and 
development. One of the last steps in the long journey of AMPARs to the synapse is 
their delivery into the specialized dendritic membrane that constitutes the postsynaptic 
terminal (Groc & Choquet, 2006). However, the precise targeting and insertion of 
receptors is extremely complicated. Despite intense study, it is still unclear whether 
AMPARs are first inserted into extrasynaptic plasma membrane or directly into 
synapses.  Some theories support the idea that AMPARs first are exocytosed into the 
plasma membrane at extrasynaptic sites, followed by their lateral diffusion at the 
neuronal surface until they reach dendrites and are finally trapped at synapses through 
anchoring in the PSD (Figure 3B) (Groc & Choquet, 2006; Shepherd & Huganir, 2007). 
Initial studies with epitope-tagged transfected receptors have suggested that AMPARs 
are inserted along dendrites in a subunit-specific manner (Passafaro et al., 2001) and a 
recent study using an innovative method to measure receptor insertion of AMPARs has 
suggested that most receptors are predominantly exocytosed at extrasynaptic sites 
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(Adesnik et al., 2005). Silencing of surface AMPARs with a membrane-impermeable 
photoreactive AMPAR antagonist allowed measuring the real-time trafficking of native 
AMPARs electrophysiologically. The recovery of synaptic receptors measured was 
surprisingly slow, taking hours rather than minutes, and the fast cycling of surface 
AMPARs from intracellular pools occurred almost exclusively at extrasynaptic somatic 
sites, on a much smaller timescale, suggesting that newly inserted extrasynaptic 
AMPARs travel along dendrites to synapses by lateral diffusion (Adesnik et al., 2005; 
Groc & Choquet, 2006; Santos et al., 2009). More recently, in an attempt to understand 
the mechanisms underlying this lateral diffusion of AMPARs, several studies showed 
evidences that the exchange of receptors from extrasynaptic to synaptic sites depends on 
the interaction of Stargazin with PSD-95, since disruption of this interaction increases 
AMPAR surface diffusion and prevents AMPAR accumulation at synapses (Bats et al., 
2007; Santos et al., 2009), suggesting that the stargazin-PSD-95 complex is critical for 
the retention of AMPARs at the synapse. 
However, these data are inconsistent with many studies, including results from 
the same laboratory, that found more rapid insertion of AMPARs into the plasma 
membrane at dendrites and synapses (Lu et al., 2001). This would be possible if 
AMPARs were trafficked intracellularly into dendrites via cytoskeleton-associated 
motors and then directly inserted at synaptic sites, a hypothesis recently supported by 
two studies (Figure 3A). Real-time measurements of receptor exocytosis in organotypic 
hippocampal slice cultures using time-lapse two-photon laser microscopy and AMPAR 
subunits tagged with super-ecliptic pHluorins (SEP) (green-fluorescent protein variants 
with strong pH-dependent fluorescence) showed that the strengthening of glutamatergic 
synapses by NMDAR activation selectively increased GluA1-containing receptors in 
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spine surfaces with no significant net change on the nearby dendrite (Groc & Choquet, 
2006; Kopec et al., 2006; Santos et al., 2009). 
 
Figure 3 – Targeting and insertion of AMPARs in the synaptic membrane. Two 
hypotheses are proposed. (A) AMPARs are transported along dendrites by the cytoskeleton 
machinery into the synapses, where they are directly inserted by exocytosis. (B) The other 
possibility suggests that AMPARs are firstly exocytosed in extrasynaptic sites, travelling then 
by lateral diffusion to the synaptic membrane where they are ultimately anchored to the PSD 
[Adapted from (Shepherd & Huganir, 2007)]. 
 
Accordingly, another study found that overexpression of a dominant negative 
form of a subunit of the exocyst complex impaired the insertion of receptors at the spine 
surface, promoting their accumulation intracellularly, suggesting that Exo70 mediates 
AMPAR budding from intra-spine compartments directly within the PSD rather than at 
extrasynaptic membranes (Gerges et al., 2006; Santos et al., 2009). Most likely, a 
combination of all these mechanisms occurs, possibly depending on the subunit 
                                                                                                                                                 Introduction 
 
 
21 
composition of the receptors and the context of the neuron activity state (Shepherd & 
Huganir, 2007).  
Moreover, many studies have shown that the mechanisms regulating AMPAR 
exocytosis are subunit specific. While GluA2 insertion is rapid and occurs constitutively 
under basal conditions, without the need for synaptic activity, GluA1 exocytosis is slow 
but inducible, requiring the activation of NMDARs or stimulation with insulin 
(Passafaro et al., 2001). Although both subunits ultimately concentrate in synapses, 
GluA2 subunit accumulation in these structures is faster than that of the GluA1 subunit 
which, given the different hypothesis of exocytosis, suggests that either the GluA1 is 
inserted initially at extrasynaptic sites, whereas GluA2 subunit is inserted more directly 
at synapses, or that both subunits are inserted at extrasynaptic sites but the GluA2 
subunit diffuses faster in the membrane and thus accumulate faster in synapses (Groc & 
Choquet, 2006). Hence, given that endogenous AMPARs consist mostly of either 
GluA1/2 or GluA2/3 heteromers, and that GluA1 trafficking signals dominate over 
GluA2 in controlling insertion (Shepherd & Huganir, 2007), a simple model has been 
proposed based on these subunit-specific trafficking rules: GluA2/3-containing 
receptors are continuously cycling in and out of synapses, preserving the total number 
of synaptic AMPARs (the constitutive pathway), whereas GluA1/2 receptors are added 
into synapses in an activity-dependent manner during synaptic plasticity (the regulated 
pathway) (Malinow et al., 2000). Therefore, the constitutive pathway may maintain 
synaptic strength despite protein turnover, and the regulated pathway may act 
transiently upon the induction of synaptic plasticity (Shepherd & Huganir, 2007). 
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Endocytosis 
In addition to their regulated trafficking and insertion into the synaptic 
membrane, the expression of AMPARs in the synapse is also dependent on their 
regulated internalization (Gomes et al., 2003). This process is thought to occur through 
clathrin-mediated endocytosis (Man et al., 2000) in specializations stably positioned 
adjacent to the postsynaptic membrane in dendritic spines. These endocytic zones lie in 
lateral domains of the spine, and they develop and persist independently of synaptic 
activity (Blanpied et al., 2002). Furthermore, their localization in close proximity to the 
PSD was found to play an important role in maintaining synaptic AMPARs and in 
sustaining basal excitatory neurotransmission.  
Endocytosis of AMPARs is similar to the stimulated endocytosis of G-protein 
coupled receptors (Carroll et al., 2001) in that both processes occur via clathrin-coated 
pits and require analogous proteins of the core endocytic protein machinery, such as 
dynamin and endophilin, essential for endosome formation, as well as AP-2 that links 
specific cargo with the clathrin lattice. Indeed, the expression of a dominant-negative 
form of dynamin was shown to block clathrin-mediated endocytosis, and consequently, 
the endocytosis of AMPARs (Carroll et al., 1999). However, postsynaptic endocytosis 
of receptors is thought to be mediated by specific protein isoforms. Dynamin 2 and 3, 
GTPases with a crucial role in severing the neck of invaginated clathrin-coated vesicles, 
are mostly postsynaptic and localized to the PSD via their interaction with the 
postsynaptic scaffolding proteins Shank and Homer, respectively (Gray et al., 2003; 
Okamoto et al., 2001). Likewise, distinct isoforms of endophilins (2 and 3) are localized 
to postsynaptic membranes (Shepherd & Huganir, 2007). Moreover, other postsynaptic 
proteins, such as the one encoded by the immediate-early gene CPG2 (Cottrell et al., 
                                                                                                                                                 Introduction 
 
 
23 
2004), and the Arc/Arg3.1 protein, also encoded by an immediate-early gene 
(Chowdhury et al., 2006), are thought to selectively promote the endocytosis of 
AMPARs. 
Furthermore, the internalization of AMPARs can be caused upon several stimuli, 
such as the activation of NMDA or insulin receptors (Carroll et al., 1999; Man et al., 
2000), with the subsequent activation of downstream signaling pathways. Thus, 
depending on the endocytic stimulus and activated signaling cascade, AMPARs can be 
differentially sorted between recycling and degradative pathways following 
endocytosis. These divergent pathways are in the basis for mechanisms of synaptic 
plasticity and in the regulation of basal neurotransmission. Following their 
incorporation in clathrin-coated pits, endocytic vesicles carrying membrane-bound 
receptors are targeted to the early endosome, from where they are sorted to either a 
recycling endosome or a late endosome. AMPARs sorted to the late endosome are 
usually fused with lysosomes and subsequently degraded, and this mechanism may 
underlie LTD phenomena. Receptors targeted to recycling endosomes can then be 
reinserted into the synaptic membrane, allowing the maintenance of a stable pool of 
AMPARs in synapses, which in turn underlies LTP phenomena. Moreover, these 
sorting cycles between recycling/degradation pathways can also underlie scaling 
mechanisms associated with homeostatic plasticity (Hanley, 2010). 
 
AMPA receptors in synaptic plasticity 
As previously mentioned, it is thought that the modulation of AMPARs, through 
mechanisms such as the regulation of the stoichiometry of subunits, RNA processing 
events, post-translational modifications, interacting proteins and other events that highly 
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impact and mediate the trafficking mechanisms and localization of AMPARs, underlies 
the phenomena of synaptic plasticity. 
Learning and memory as well as other processes involved in all human behaviour are 
possible due to the ability of the mammalian brain to undergo experience-based 
adaptations. Such plasticity is exquisitely regulated by highly intricate molecular 
mechanisms (Fleming & England, 2010; Shepherd & Huganir, 2007) and it occurs at 
the level of synapses that become stronger or weaker in response to specific patterns of 
activity. These changes mediate the efficiency of synaptic transmission and, 
consequently, the activity of neuronal networks, ultimately representing the cellular 
correlate of learning and memory. The basic mechanism for activity-dependent synaptic 
plasticity was first formally postulated by D.O. Hebb in 1949, who stated that when pre- 
and post-synaptic cells are repetitively active together, the efficiency of transmission 
between them improves (Hebb, 1949). Only in 1973, Hebb’s theory gained 
experimental support with the impacting observation, by Bliss and Lømo, that repetitive 
activation of excitatory synapses in the hippocampus triggered a persistent increase in 
synaptic transmission lasting hours and even days (Bliss & Lomo, 1973). This long-
lasting increase in synaptic strength, upon a short period of high-frequency stimulation, 
has been termed long-term potentiation (LTP), and the converse process, a persistent 
weakening of synaptic strength relative to baseline triggered by prolonged low-
frequency stimulation, has been termed long-term depression (LTD) (Genoux & 
Montgomery, 2007; Santos et al., 2009). Despite being the most thoroughly studied 
forms of synaptic plasticity, the molecular mechanisms mediating LTP and LTD are 
still unclear. 
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 In general, two molecular mechanisms seem to underlie the changes in synaptic 
strength: either changes in the amount of neurotransmitters released by presynaptic 
neurons into the synaptic cleft or changes in the number and function of receptors on the 
postsynaptic neuron that respond to those neurotransmitters (Fleming & England, 
2010). This second mechanism has gained particular support in the last decade, even 
though Lynch and Baudry had already proposed an increase in the number of synaptic 
GluRs during LTP more than twenty years ago (Lynch & Baudry, 1984). This idea 
came back to light after electrophysiological experiments suggested the existence of 
‘silent synapses’ (Isaac et al., 1995). These synapses, lacking AMPARs but with 
NMDARs, upon induction of LTP are converted to ‘functional’ synapses by delivery of 
AMPARs to the synaptic membrane, which prompted the idea that at excitatory 
synapses the insertion or removal of AMPARs from the PSD underlie the changes in 
synaptic strength associated with LTP and LTD, respectively (Santos et al., 2009).  
 
AMPA receptors in long-term potentiation (LTP) 
AMPARs in the adult hippocampus contain GluA1/2 or GluA2/3 heteromers, 
but several lines of evidence point to a central role for the GluA1 subunit in 
hippocampal LTP, since knockout mice for GluA1 subunit were reported to be deficient 
in LTP (Zamanillo et al., 1999). Accordingly, studies in organotypic hippocampal 
cultures transiently expressing GFP-tagged AMPARs showed a rapid translocation of 
GluA1-GFP to dendritic spines following LTP (Shi et al., 1999). Moreover, the rapid 
translocation of this central subunit to the synaptic membrane requires a high-frequency 
stimulation and is highly dependent on the activation of NMDARs (Shi et al., 1999), 
which is consistent with what was described earlier, suggesting the activity-dependent 
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insertion of GluA1-containing AMPARs in the synaptic membrane. Furthermore, it was 
shown that the re-insertion of GluA1-containing AMPARs into the plasma membrane 
from recycling endosomes is enhanced in response to LTP-inducing stimuli (Figure 
4A), contributing not only to enhance synaptic efficacy but also to supply lipid 
membrane for the extension of dendritic spines during this phenomenon (Park et al., 
2004). Thus, these results seem to suggest the need of a stable pool of GluA1-
containing AMPARs in close proximity to synaptic sites for the rapid modulation of the 
synaptic membrane upon LTP induction. Recent data by Isaac and collaborators suggest 
that GluA1 homomers are the first channels to be inserted during LTP, contributing to 
the early remodelling of synapses that occurs in the initial phases of this phenomenon, 
with a subsequent switch to GluA2-containing heteromers, thought to contribute to the 
consolidation of LTP (Figure 4A) (Plant et al., 2006) although this finding remains 
controversial (Adesnik & Nicoll, 2007). Also, the changes in synaptic activity, based on 
the cycling of AMPARs in and out of synapses, are highly dependent on the 
phosphorylation of receptors and many studies support a critical role for CaMKII- and 
PKA-dependent phosphorylation of GluA1 at Ser831 and Ser845, respectively, in LTP. 
Particularly, while phosphorylation of Ser831 by CaMKII seems to be crucial for the 
induction of LTP (Lee et al., 2000) but not required for the synaptic delivery of 
receptors (Hayashi et al., 2000), PKA-mediated phosphorylation of Ser845 is necessary, 
although not sufficient, for this event (Figure 4A) (Malinow, 2003).  
 
AMPA receptors in long-term depression (LTD) 
Regarding LTD, many studies show that this phenomenon results from the 
endocytosis of AMPARs (Figure 4B) (Beattie et al., 2000). Indeed, the activation of 
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NMDARs or insulin receptors can cause a loss of synaptically expressed AMPARs 
(Carroll et al., 1999; Man et al., 2000). Particularly, NMDAR-dependent LTD is known 
to require a moderate increase in postsynaptic calcium influx and activation of the 
calcium-dependent phosphatase calcineurin (Beattie et al., 2000). The activation of this 
phosphatase mediates the regulation of the phosphorylation of AMPAR subunits, which 
is also important for LTD expression (Fig. 4B). Thus, LTD further requires the 
dephosphorylation of the GluA1 subunit in Ser831 and 845 (Lee et al., 2000). The 
mechanisms by which these dephosphorylation states of the GluA1 subunit mediate the 
internalization of AMPARs are still unclear but may involve differential regulation of 
AMPAR binding partners (Shepherd & Huganir, 2007). Furthermore, the regulated 
endocytosis of AMPARs is also dependent of the GluA2 subunit. Interaction between 
the GluA2 subunit and the clathrin adaptor protein AP2 is required to AMPAR 
internalization, and also, phosphorylation of this subunit mediates the disruption of the 
stabilizer GluA2-GRIP interaction, resulting in the removal of synaptic AMPARs, by 
facilitation of the GluA2-PICK1 interaction (Perez et al., 2001). 
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Figure 4 – Differential AMPAR trafficking during synaptic plasticity. (A) During LTP, 
AMPARs are supplied to the synapse either through exocytosis at extrasynaptic sites or through 
direct exocytosis at the synaptic membrane. AMPARs present in a stable recycling pool can also 
provide a source of receptors to be inserted during this phenomenon. It is thought that upon 
induction of LTP, homomers of GluA1 receptors are the first to be inserted into the synapse, 
occurring then a switch to heterotetramers of GluA2-containing AMPARs. Some kinases and 
downstream signaling molecules are involved in the induction of LTP and insertion of receptors 
to the synapse. (B) AMPAR endocytosis occurs during LTD. Receptors diffuse out of the PSD 
to lateral endocytic sites where they are internalized. Phosphatases such as calcineurin are 
required for the dephosphorylation of AMPAR subunits and subsequent endocytosis. [Adapted 
from (Shepherd & Huganir, 2007)]. 
 
AMPA receptors in homeostatic plasticity 
 Many of the plastic changes that underlie developmental and learning-related 
adaptations are thought to require synapse-specific changes in synaptic strength, yet 
these processes exert a powerful destabilizing influence on network function (Abbott & 
Nelson, 2000). Hebbian types of plasticity, like LTP or LTD, are able to strengthen 
synaptic inputs that are effective at depolarizing the postsynaptic neuron and weaken 
inputs that are not, thus reinforcing useful pathways in the brain (Abbott & Nelson, 
2000; Malenka & Bear, 2004). However, these mechanisms pose a serious problem to 
the stability of neuronal networks, since synapses that are strengthened become more 
effective at depolarizing the postsynaptic neuron and will continue to be strengthened in 
an unconstrained positive feedback cycle, eventually driving neuronal activity to 
saturation (Abbott & Nelson, 2000; Turrigiano, 2008). These evidences imply that 
neurons must have some kind of sensor that detects these perturbations in their own 
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excitability and that triggers feedback mechanisms to counteract these destabilizing 
changes in activity, maintaining the homeostasis of the network.  
Experimental evidence for these adaptive compensatory mechanisms started 
erupting over a decade ago [reviewed in (Turrigiano, 1999, 2008; Yu & Goda, 2009)]. 
Initial compelling evidences suggested that circuit activity is homeostatically regulated 
to maintain firing rates and/or firing patterns within certain functional boundaries. 
Studies carried by Turrigiano et al. and Burrone et al., showed that when cortical or 
hippocampal neurons were induced to fire more than normal, over many hours, firing 
rates returned to baseline levels, and if neuronal firing was conversely reduced over 
time, neurons would also compensate and again firing rates would return to normal 
(Burrone et al., 2002; Turrigiano et al., 1998). These evidences, thus suggested that 
neuronal circuits possess mechanisms that maintain firing rates at a homeostatic set 
point.  
 Neuronal firing arises from the interplay between synaptic currents and the 
intrinsic firing properties of a neuron (Turrigiano, 2011). This would mean that the 
homeostatic regulation of excitability could impact on two major targets: intrinsic 
excitability and synaptic efficacy (Pozo & Goda, 2010). Neurons could slowly adjust 
synaptic strength and efficacy up and down in the right direction to stabilize average 
firing (Turrigiano et al., 1998) or, conversely, they could modulate intrinsic excitability 
to shift the relationship between synaptic input and firing rate (Desai et al., 1999; 
Turrigiano et al., 1994). In principle, both of these processes could work, and many 
neurons appear able to undergo homeostatic regulation of firing via either mechanism 
(Desai et al., 1999; Turrigiano et al., 1994). In this review, we will only focus in the 
synaptic counterpart of these homeostatic mechanisms.  
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Homeostatic Synaptic Scaling 
 An important function of homeostatic synaptic plasticity in central neurons is to 
compensate for developmental or learning-induced changes in synaptic strength. This 
adaptation could, in theory, occur through changes either at the postsynaptic level, by 
altering postsynaptic receptors, or through changes in presynaptic neurotransmitter 
release. The first reports of synaptic homeostasis at excitatory synapses showed that a 
chronic blockade of activity resulted in an increased excitatory synaptic transmission, 
just by changing the postsynaptic accumulation of AMPA receptors (O'Brien et al., 
1998; Turrigiano et al., 1998), with no changes in presynaptic function. Moreover, 
pharmacological manipulations of activity were shown to induce bidirectional 
compensatory changes that increased or decreased the amplitude of miniature excitatory 
postsynaptic currents (mEPSCs) mediated by AMPARs, resulting in an effective scaling 
of the postsynaptic strength up or down (Turrigiano & Nelson, 2004). Blockade of 
spiking with Tetrodotoxin (specific blocker of voltage-gated sodium channels) resulted 
in increased amplitude of mEPSCs, whereas blocking GABA-mediated inhibition with 
bicuculline (antagonist of GABAA receptors) resulted in an initial increase in firing rates 
that, over a time scale, returned to control values (Turrigiano et al., 1998). Such a 
postsynaptic scaling process is predicted to stabilize activity without changing the 
relative strength of synaptic inputs, since neurons are able to detect their activity, 
possibly through calcium-dependent sensors, and regulate their own excitability while 
preserving the relative differences between individual synapses, thus avoiding 
disruption of information-storage mechanisms. Due to this proportional change in 
postsynaptic strength, this homeostatic mechanism was termed as synaptic scaling 
(Turrigiano et al., 1998).   
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 Following these original studies that first evidenced the scaling of AMPA-
mediated minis upon chronic activity modulation, much effort has been made to clarify 
the postsynaptic mechanisms that underlie homeostatic synaptic plasticity (Pozo & 
Goda, 2010; Turrigiano, 2008). These homeostatic changes in postsynaptic strength 
result from alterations in the composition and abundance of synaptic AMPARs (O'Brien 
et al., 1998; Wierenga et al., 2005). Therefore, the postsynaptic expression of 
homeostatic plasticity possibly relies on a variety of mechanisms that mediate activity-
dependent delivery and stabilization of AMPARs at synapses (Figure 5). Interestingly, it 
was already shown that, rather than being synthesized and delivered from the cell soma, 
AMPARs are locally translated at dendrites. Ju and colleagues showed that chronic 
blockade of activity with TTX resulted in an enhancement of dendritic synthesis of 
AMPARs, as new receptors continued to accumulate when dendrites were physically 
separated from the cell body (Ju et al., 2004).  
 
Figure 5 – Homeostatic synaptic scaling is accompanied by changes in the accumulation of 
AMPA receptors at synaptic sites. In response to chronic changes in activity, neurons trigger 
homeostatic mechanisms to counteract perturbations in their excitability and restore their 
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activity to a homeostatic set point. This adaptation can occur by adjusting the trafficking and 
insertion of receptors into synapses. While chronic enhancement of neuronal activity results in 
decreased accumulation of AMPARs, blockade of activity promoted the traffic and insertion of 
novel receptors into the synapse. [Adapted from (Turrigiano & Nelson, 2004)]. 
  
 While studies agree that synaptic scaling is induced by changes in AMPAR 
accumulation at synapses, there is less agreement on the subunit composition of the 
newly inserted receptors. While some studies reported a proportional increase of both 
GluA1 and GluA2 subunits of AMPARs upon blockade of activity (O'Brien et al., 1998; 
Wierenga et al., 2005), other studies report only the postsynaptic recruitment of GluA1 
but not GluA2 (Ju et al., 2004; Sutton et al., 2006). Moreover, Ju and colleagues further 
describe that this accumulation of GluA1 to the synapse upon blockade of activity is 
due to the specific enhancement of GluA1 dendritic synthesis. Altogether these 
evidences seem to propose that synaptic scaling may occur as a consequence of 
regulatory mechanisms that not only change AMPAR traffic and synaptic insertion 
upon changes in activity, but also regulate the dendritic availability of AMPARs 
transcripts and their local translation. 
 
Molecular pathways underlying synaptic scaling 
 Since the first descriptions of homeostatic plasticity and synaptic scaling, the 
knowledge on the cellular properties of this type of plasticity has increased 
significantly. However, the molecular mechanisms that underlie this negative feedback, 
by which synaptic strength is adjusted, are still poorly understood (Pozo & Goda, 2010). 
Nevertheless, novel players, whole loss of function interferes with the expression of 
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homeostatic plasticity, have been identified and contribute to emphasize the complexity 
of possible signaling pathways that neurons use to maintain their homeostasis.  
 One of the first identified players was the immediate-early gene Arc/Arg3.1. Arc 
protein is rapidly induced by the chronic changes in activity used to promote synaptic 
scaling in vitro. Also, overexpression of the protein results in decreased AMPAR-
mediated currents and prevents the increase in mEPSC amplitude induced by chronic 
TTX. Conversely, knockdown of Arc elevates AMPAR-mediated transmission and 
occludes the effect of TTX on mEPSCs (Rial Verde et al., 2006; Shepherd et al., 2006). 
Finally, the effect of Arc in AMPAR-mediated currents seems to occur via its ability to 
activate a novel and selective AMPAR endocytic pathway (Chowdhury et al., 2006). 
Other players involved in mechanisms that regulate the expression of 
homeostatic plasticity are β3 integrins. A recent study showed that, under basal 
conditions, β3 integrins act to stabilize synaptic AMPARs and loss of function of these 
cell adhesion molecules specifically impaired the homeostatic scaling of mEPSCs 
mediated by a TTX-induced blockade of activity. Thus, this study not only suggests a 
specific postsynaptic requirement for β3 integrins in scaling up of AMPARs but also an 
important contribution of the extracellular matrix in coordinating homeostatic plasticity 
(Cingolani et al., 2008).  
Several studies have also proposed a role for some secreted molecules in shaping 
homeostatic adaptations of synaptic strength. Stellwagen and Malenka showed that 
TNFα, a pro-inflammatory cytokine produced by glial cells, upregulated the cell surface 
expression of AMPARs as well as their synaptic insertion, upon pharmacological 
blockade of activity. This resulted in a compensatory increase in AMPAR-mediated 
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currents and thus, implicated TNFα in the regulation of the mechanisms inducing 
synaptic scaling (Stellwagen & Malenka, 2006). 
Finally, Retinoic acid (RA) has just recently been included in the list of 
molecules that are implicated in mechanisms of homeostatic plasticity. In a recent 
study, blockade of activity with TTX and APV to induce synaptic scaling also resulted 
in an increased synthesis of RA (Aoto et al., 2008). Moreover, applying RA by itself 
induced synaptic scaling of AMPARs, occluding the same effect induced by TTX. Also, 
this scaling of AMPARs induced by RA was due to an increased local synthesis of the 
GluA1 subunit, through signaling via the RA receptor RARα (Aoto et al., 2008; 
Maghsoodi et al., 2008).  
 
The Caspr1/Contactin1 complex 
 Contactin 1 associated protein (Caspr1), also known as paranodin, is a type I 
integral membrane protein of 190kDa, highly expressed in the CNS and it was first 
described as an interactor for the cell adhesion molecule Contactin1 (Einheber et al., 
1997; Peles et al., 1997). These two proteins form a heterodimer that localizes to 
neuronal membranes, particularly to paranodal junctions shortly after the onset of 
myelination (Einheber et al., 1997). 
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Figure 6 – Schematic representation of Contactin and Caspr1. The extracellular domain of 
Caspr1 has a discoidin domain next to the N-terminal, four laminin G domains, two repeats 
EGF-like and several PGY (Pro – Gly – Tyr) repeats. Its intracellular C-terminal has a region 
for the binding of FERM domains and a sequence rich in proline residues. Contactin presents a 
modular structure composed of 6 Ig domains and 4 repeats of the fibronectin domain. 
 
Contactin1 is a glycoprotein of the immunoglobulin superfamily (Ig) and it 
presents a modular structure with repeats of the Ig domain and of a fibronectin domain 
(Figure 6). Caspr1, on its turn, is composed by a mosaic of domains, typically involved 
in protein-protein interactions. Since it belongs to the family of neurexins, its overall 
extracellular architecture is very similar to that of neurexins and it contains a discoidin 
domain next to its N-terminal, several sequences with homology to the extracellular 
matrix proteins laminin A, agrin, slit and perlecan, two epidermal growth factor (EGF)-
like regions, a central fibrinogen domain and several PGY (proline – glycine – tyrosine) 
repeats (Figure 6).  
Its intracellular C-terminal tail, on the other hand, possesses particular interest, 
since it contains a juxtamembrane region for the binding of molecules containing 
FERM domains, such as protein 4.1N (or 4.1B), schwannomin and β-integrin1 
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(Denisenko-Nehrbass et al., 2003a; Denisenko-Nehrbass et al., 2003b), and a sequence 
rich in proline residues, with at least one canonical SH3-domain binding site, which 
suggests the interaction of Caspr1 with several molecules typically involved in signaling 
pathways (Peles et al., 1997). In fact, it has already been shown the selective interaction 
between the C-tail of Caspr1 and the SH3 domains of Src, Fyn, p85 and PLCγ in in 
vitro essays (Figure 6) (Peles et al., 1997). Moreover, the interaction between Caspr1 
and Src was further confirmed when both proteins were exogenously expressed in co-
transfected COS7 cells: immunoprecipitation with several c-Src-specific antibodies was 
able to co-precipitate Caspr1 from lysates of transfected cells (Peles et al., 1997).  
Caspr1 was one of the first constituents of the paranodal junctions to be 
identified (Einheber et al., 1997; Menegoz et al., 1997). Biochemical studies showed 
that Caspr1 associates in cis with Contactin1 (Peles et al., 1997), and this complex is 
highly enriched in the paranode junctions, septate-like junctions that seal the 
myelinizing sheath to the axonal membrane, and thus, permit the anchoring of myelin to 
axons (Rios et al., 2000), exerting a quite well characterized function in the process of 
myelinization. Mice that lack Caspr1 exhibit tremor, ataxia and motor paresis (Bhat et 
al., 2001). Moreover, in the absence of Caspr1 there is a perturbation of the paranodal 
organization and altered distribution of the junctional components, such as Contactin1 
and neurofascin-155. Accordingly, the nerve conduction velocity is markedly reduced in 
Caspr1 mutant mice (Bhat et al., 2001). 
 
Intracellular traffic of the complex Caspr1/Contactin1 
 Up until now, the information available about the regulation of Caspr1 concerns 
its intracellular traffic. Apparently, the interaction between Contactin1 and Caspr1 is 
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essential for its expression at the cell surface. The interaction between these two 
proteins occurs in the ER and is mediated by the GPI anchor, the FNIII repeats and the 
IgG regions of Contactin1. This interaction is required for an efficient recruitment of 
Caspr1 to lipid rafts and sorting to the plasma membrane (Boyle et al., 2001; Faivre-
Sarrailh et al., 2000).  
Both Caspr1 and Contactin1 are essential for the generation of the axoglial 
junction, and their absence results in the disappearance of septa and widening of the 
space between the axon and the paranodal loop (Bhat et al., 2001; Boyle et al., 2001). In 
transgenic mice, the extracellular region of Caspr1 is sufficient for directing it to the 
paranodes and the retention of the Caspr1/Contactin1 complex at the junction depends 
on the presence of an intact cytoplasmic domain of Caspr1 (Gollan et al., 2002). This 
region is able to bind to the cytoskeleton associated protein 4.1, allowing Caspr1 to 
stabilize the Caspr1/Contactin1 adhesion complex at the paranodal junction by 
connecting it to cytoskeletal components within the axon. Moreover, expression of 
Caspr1 on its own, in neuroblatoma cells, resulted in its ER retention, a phenomenon 
that seems to be dependent on an ER retention signal located in the extracellular PGY-
repeat region of Caspr1 (Bonnon et al., 2007; Bonnon et al., 2003).  
 
Synaptic role of Caspr1/Contactin1 complex 
Both Contactin1 and Caspr1 have already been found in synaptic sites, 
throughout dendrites of CA1 area cultured hippocampal neurons, where they co-localize 
with synapsin-1 and synaptophysin (Murai et al., 2002). Thus, by anchoring to the 
synaptic membrane, the complex Caspr1/Contactin1 might regulate intracellular 
interactions required for changes in synaptic strength, for example. Contactin1 was 
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shown to have a function in synaptic plasticity, particularly in LTD: whole-cell 
recordings from CA1 pyramidal cells revealed that mice with disrupted Contactin1 gene 
expression are specifically impaired in paired pulse facilitation (PPF) and LTD. 
Ablation of Contactin1 did not affect the development of the synaptic ultrastructure in 
the CA1 area (Murai et al., 2002), but a molecular analysis indicated that Contactin1 is 
essential for the membrane and synaptic targeting of Caspr1 (Murai et al., 2002). 
Another study investigated whether mice mutant for Caspr1 have deficits in synaptic 
plasticity and axonal organization similar to those observed in Contactin1 mutants, but 
according to this study, Caspr1 mutants have normal synaptic transmission and 
plasticity in the CA1 region of the hippocampus (Pillai et al., 2007). 
 
Role of Caspr1 in AMPA receptors regulation 
Just recently, a study carried out in our laboratory suggests that the complex 
Caspr1/Contactin1 may regulate the transport of AMPA receptor subunits as well as 
their genetic expression. By combining affinity purification of protein complexes with 
mass spectrometric analysis of their composition, Santos et al., were able to identify 
Caspr1 as a novel binding partner for AMPARs, particularly for the GluA4 subunit. 
Later on, performing immunoprecipitation and pull-down assays they found 
biochemical evidences suggesting Caspr1 as a strong interactor also for the GluA1, 
GluA2, GluA2L subunits (Santos, 2009; Santos et al., 2010).  
Also, biotinylation assays showed that overexpression of Caspr1 and Contactin1 
leads to an increase in GluA1 cell surface levels and electrophysiology studies indicated 
that the C-terminal domain of Caspr1 increases the amplitude of AMPAR-mediated 
miniature excitatory postsynaptic currents (mEPSCs), which suggests that the 
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intracellular region of Caspr1 increases the traffic of AMPARs to synapses (Santos, 
2009). 
Furthermore, in addition to affecting AMPAR traffic, preliminary results 
indicated that Caspr1 slightly increases GluA1 total protein levels, without affecting 
protein stability. This result prompted the idea that the increase in GluA1 levels could 
be due to an effect of Caspr1 in GluA1 mRNA levels, which was confirmed by 
quantitative real-time PCR experiments. These preliminary results suggest, then, that 
the complex Caspr1/Contactin1 may regulate the expression and, possibly, the stability 
of GluA1 AMPAR subunit and, hence, participate in the modulation of synaptic 
strength involving changes in AMPARs (Santos, 2009). 
 Nevertheless, how Caspr1 promotes this upregulation of GluA1 mRNA levels is 
still not known. One hypothesis is that the effect of Caspr1 is mediated through a direct 
interaction with RNA-binding proteins. A similar mechanism has been described for the 
transmembrane stargazin-related protein γ7 that regulates the stability of the calcium 
channel Cav2.2 mRNA by binding through its C-terminal to the hnRNP A2, and 
preventing hnRNPA2 from binding to the Cav2.2 mRNA (Ferron et al., 2008). 
Moreover, given the structure of the C-terminus of Caspr1, another possibility is that the 
upregulatory effect of Caspr1 is through the activation of signaling cascades that result 
in altered RNA binding protein activity. 
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Post-transcriptional regulation of the GluA1 AMPA receptor subunit 
 The regulation of transcription and translation is an obvious mechanism to 
control gene expression. In neurons, these mechanisms are highly dynamic and complex 
and have become essential regulatory mechanisms for proper neuronal function. 
 
Local Protein Synthesis in Dendrites 
 Nowadays, it is well established that the consolidation of LTP (late-phase LTP) 
requires gene transcription and is highly dependent on new protein synthesis. This set of 
newly synthesized proteins can include not only AMPAR subunits, but also proteins 
necessary for the trafficking of the receptors or for their anchoring in the synapse, as 
well as proteins involved in the structural remodelling of dendritic spines that occurs 
during LTP (Derkach et al., 2007). Indeed, the modulation of synaptic strength is also 
dependent on the modulation of AMPARs, either by changing the composition in 
subunits of receptors already expressed at the synapse or by the rapid recruitment of 
new receptors to this structure. However, the complex polarized structure of neurons 
poses a problem for this rapid synthesis and transport of subunits and receptors, 
required for neuronal plasticity, all the way from the cell body to dendritic spines. Thus, 
the exclusive dependence of plasticity phenomena in somatic protein synthesis would 
probably result in low efficiency of these mechanisms and impair synaptic plasticity, 
and consequently, memory formation and storage. This idea prompted the possibility of 
the occurrence of local dendritic protein synthesis underlying the many forms of long-
term synaptic plasticity. 
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Up until recently, the lack of evidences for such a mechanism as local dendritic 
translation led neuroscientists to believe that proteins were only made in the cell body. 
mRNAs would be translated in the ER and translocated to the Golgi apparatus and, only 
then, the resulting protein would be transported to its target, the dendritic spine, for 
example, through the cytoskeleton machinery. Only when Steward and Levy, back in 
1982, detected the presence of polyribosomes in the distal dendrites of dentate granule 
cell neurons (Steward & Levy, 1982), did the possibility of local protein synthesis start 
to be taken seriously (Sutton & Schuman, 2006).  Later studies further showed that the 
entire translational machinery is present in dendrites, since, besides ribosomes, initiation 
and elongation factors for translation have also been found in these neuronal processes 
(Asaki et al., 2003). Throughout these most recent years, several were the mRNAs 
found to be localized in dendrites, most of them coding for synaptic proteins involved in 
the modulation of synaptic strengthening and synaptic transmission, such as mRNA 
encoding for the microtubule-associated protein 2 (MAP2), the alpha-subunit of 
calcium-calmodulin-dependent protein kinase II (CaMKII), the brain-derived 
neurotrophic factor (BDNF), the activity-regulated cytoskeleton-associated protein 
(Arc), the tyrosine-related kinase B receptor (TrkB), the IP3 receptor, the atypical 
protein kinase Mζ, the NMDAR GluN1 subunit and the glycine receptor alpha-subunit, 
among many others (for a review see [(Martin & Zukin, 2006; Schuman et al., 2006)]. 
Thus, the subcellular targeting and localization of specific mRNAs to distinct regions 
provides an important means to regulate the gene expression in neurons and the activity-
induced translational control of these localized mRNAs allows neurons to alter protein 
composition of specific synapses with great temporal and spatial resolution (Holt & 
Bullock, 2009; Poon et al., 2006). 
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Since more mRNAs are continually being found in dendrites, suggesting that the 
number of different mRNA species in these neurites could reach the several hundred, it 
is difficult to evaluate the full spectrum of synaptic functions that this local translation 
might be regulating (Sutton & Schuman, 2006). Furthermore, the mechanism by which 
a specific mRNA is transported to a specific synaptic site is still largely a mystery. Still, 
neurons have somehow developed specific pathways that enable the transport of 
mRNAs to dendrites, where subsequently local translation can occur. Nevertheless, a 
model for mRNA transport and localization in dendrites is emerging (Figure 7). Not 
every step in this model has been verified for any single mRNA; rather, the model is a 
combination of data generated from observations of multiple different mRNAs 
(Bramham & Wells, 2007).  
 
 
Figure 7 – Proposed model for mRNA transport and local translation in neuronal 
dendrites. Specific mRNAs can bind to mRNA-binding proteins that inhibit the translation of 
the mRNA in the protein-synthetic apparatus in the cell body. The repressed mRNA can then be 
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packaged and sequestered into transport granules that travel into the dendrites by kinesin motors 
on the microtubule-based cytoskeleton. Following synaptic activation, the granules are 
dispersed and the mRNA is localized to spines by the actin-based myosin motor proteins, 
where, after the repressive RNA-binding protein is neutralized, the mRNA is free to be 
translated [Adapted from (Bramham & Wells, 2007)]. 
 
Thus, it is widely accepted that most mRNAs are transported as part of large 
RNA-containing granules, namely large ribonucleoprotein particles (RNPs) containing 
proteins involved in RNA transport, protein synthesis, RNA helicases, heterogeneous 
nuclear ribonucleoproteins (hnRNPs), and RNA-associated proteins (Hirokawa, 2006). 
Moreover, it is thought that the mRNAs present in these granules are in a translationally 
dormant state, until a specific stimulus is able to activate translation (Martin & Zukin, 
2006). This translational repression is likely to occur in the nucleus, where the mRNAs 
may bind to RNA-binding proteins that sequester the transcripts from the translational 
machinery in the cell body and mediate their inclusion into the RNPs. Following this 
incorporation, the granules travel along dendrites through the interaction with kinesin 
motors on the microtubule-based cytoskeleton. Upon synaptic activation, the granules 
can be dispersed and the repressed mRNAs are incorporated by the actin-based myosin 
motor proteins into spines, where the repressor binding protein is neutralized, leaving 
mRNAs free to be translated (Figure 7) (Bramham & Wells, 2007). Besides RNPs, 
different cytoplasmic macromolecular RNA structures exist in neurons, such as 
processing bodies (P-bodies) and stress granules (Sossin & DesGroseillers, 2006). The 
relationship between transport RNPs, P-bodies and stress granules is not currently 
understood, but these different granules are thought to be functionally distinct. P-bodies 
are mostly known to be foci of mRNA degradation, since they recruit mRNAs targeted 
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for deadenylation and degradation. Nonetheless, they are also thought to have a dual 
function: they can harbour translationally silenced mRNAs that can later exit again from 
P-bodies and re-engage in translation (Kulkarni et al., 2010). As for stress granules, 
they are generated in response to stress, sequestering mRNAs from translation as a 
means to adapt the mRNA metabolism to the changing conditions (Sossin & 
DesGroseillers, 2006). Despite this model, the actual mechanism of regulation of local 
dendritic translation is still far from being completely understood. What determines the 
targeting of certain specific mRNAs to specific synaptic sites? How exactly is this 
mechanism regulated and what are the RNA-binding proteins that associate specifically 
with each mRNA? Do they have a role only in the translational control of these 
transcripts or do they also regulate their stability? These are some questions that are still 
not fully answered and that will be focused later. 
 
Local Dendritic Synthesis of AMPA Receptor Subunits 
One of the possible mechanisms to control the composition of AMPARs during the 
modulation of synaptic strength, upon neuronal activity, is through local translation at dendrites, 
in close proximity to synaptic sites, of mRNA molecules for specific AMPAR subunits. 
Accordingly, quite recently, a couple of studies showed that a substantial fraction of synaptic 
sites contain mRNA molecules for the GluA1 and GluA2 AMPAR subunits, which is consistent 
with a strategic positioning of these molecules for their local translation, and thus, allowing the 
regulation of the local abundance of receptors, as well as their composition and insertion to the 
membrane (Figure 8) (Grooms et al., 2006; Ju et al., 2004; Kacharmina et al., 2000).  
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Figure 8 – Local dendritic synthesis of AMPARs. Several studies propose the local synthesis 
of GluA1/2 subunits in dendrites. These mRNA molecules can be trafficked out into dendrites 
via a RNA-protein complex travelling along the cytoskeleton. In synapses, mRNA can be 
translated upon neuronal activity [Adapted from (Shepherd & Huganir, 2007)]. 
 
Using biarsenical dyes, FlAsH and ReAsH, Malenka and collaborators showed 
that exogenously expressed GluA1 and GluA2 subunits can be synthesized in specific 
dendritic compartments, independently of the cell soma (Ju et al., 2004). Moreover, 
they demonstrated that the pharmacological manipulation of neuronal activity, such as 
the activation of metabotropic glutamate receptors or the acute depolarization with KCl 
led to an increase in the synthesis of both GluA1 and GluA2 subunits, whereas a 
chronic blockade of synaptic activity, known to increase the strength of synapses by an 
accumulation of AMPARs, could specifically increase the dendritic synthesis of the 
GluA1 subunit (Ju et al., 2004). Zukin and associates were also able to find endogenous 
mRNA molecules for GluA1 and GluA2 subunits localized to distal and proximal 
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dendrites in hippocampal neurons (Grooms et al., 2006). They also suggested that the 
local abundance and localization of these mRNAs can be controlled by paradigms that 
manipulate glutamatergic signaling. That is, the activation of NMDARs results in a 
decrease of mRNA abundance, dependent on a higher influx of intracellular calcium 
and on the activation of the ERK (extracellular signal-regulated kinase) / MAPK 
(mitogen-activated protein kinase) signaling pathway, whereas the activation of 
metabotropic glutamate receptors increases GluA1 dendritic mRNA, by upregulating 
the anterograde transport of mRNA through the cytoskeleton machinery (Grooms et al., 
2006). These results, as it happens for the general mechanism of local dendritic 
translation, raise some doubts concerning the regulation of AMPAR subunits local 
synthesis. How are GluA1 and GluA2 transcripts targeted to specific synaptic sites? 
How is their transport regulated? Which proteins are binding to the mRNAs and 
repressing their translation? Is this regulatory mechanism also influencing the decay and 
stability of the transcripts? 
 
Pathways of mRNA stability and turnover 
 In all organisms, the process of protein synthesis must be precisely regulated in 
order to minimize the energy costs for cells, and in many circumstances cells need to 
rapidly adapt the amount of specific proteins being produced. To achieve this, cells have 
developed the ability to degrade mRNAs so that patterns of protein synthesis can be 
altered rapidly, and thus, mRNA degradation directly affects protein synthesis through 
its impact on the concentration of mRNA available for translation (Belasco, 2010). This 
requirement may explain why mRNA stability is such a highly regulated post-
transcriptional step, tightly coordinated with mRNA translation. mRNAs can either be 
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translated immediately or be sequestered such that they can later undergo translation or 
be degraded. In the latter case, several factors can modulate the decay rate of a certain 
mRNA and mediate the interrelationship between degradation and translation (De 
Rubeis & Bagni, 2010). 
 
Pathways of mRNA turnover 
 In mammals, two major pathways for mRNA degradation have been described, 
being the most important the deadenylation-dependent mRNA decay. mRNAs are 
created with two integral stability determinants – the 5’ 7-methylguanosine cap and the 
3’ poly(A) tail – that are incorporated co-transcriptionally. These two structures can 
protect transcripts from exonucleases and enhance the initiation of translation of the 
transcripts. Thus, in order to initiate decay, either one of these structures must be 
compromised or the mRNA must be cleaved internally by endonucleolytic attack 
(Garneau et al., 2007; Wilusz et al., 2001). In higher eukaryotes and also in yeasts, most 
mRNAs undergo decay by a pathway that is initiated by poly(A)-tail shortening. Once 
an mRNA is targeted to be destroyed by the cell, one of two irreversible routes can take 
place. Either the unprotected 3’ end is attacked by the exosome, a large complex with 3’ 
→ 5’ exonucleolytic activity, or the 5’ cap is cleaved by a process known as decapping, 
which allows the mRNA body to be degraded in the 5’ → 3’ direction. However, 
despite the intense study dedicated to mRNA turnover, there are still some aspects 
concerning the enzymes, pathways and regulation of this mechanism that remain 
unclear. Apart from this, mRNA decay is now considered a key player in the regulation 
of gene expression (Garneau et al., 2007; Wilusz et al., 2001).   
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mRNA Stability and Turnover – Role of RNA-binding Proteins 
 As it was discussed until this point, post-transcriptional gene regulation, 
including mRNA turnover and translation, is an important way of regulating gene 
expression. In the CNS, there is a growing number of genes whose expression levels are 
controlled by changes in the rate of mRNA decay, and thus, involve a balance between 
mRNA stability and turnover (Perrone-Bizzozero & Bolognani, 2002). This balance 
may involve the interaction of transcripts with specific RNA-binding proteins. 
Examples of neuronal genes regulated via mRNA stability involving the interaction 
with a RNA-binding protein include developmentally regulated proteins, such as GAP-
43 (Benowitz & Routtenberg, 1997); signaling molecules, such as calmodulin and 
CAMKII (Wu et al., 1998); receptors, such as the β2-adrenergic receptor 
(Tholanikunnel et al., 1999), the m4 muscarinic receptor (Lee & Malek, 1998) and the 
dopamine receptor D2 (Duan et al., 2003); as well as channels, such as the Cav2.2 
calcium channel (Ferron et al., 2008).  
 In most cases, it is thought that the decay rate of mRNAs is regulated by 
interactions of the aforementioned sequence-specific RNA-binding proteins to cis-
acting elements frequently located in the 3’untranslated region (3’UTR) of the 
transcripts. Several examples of this type of regulation over mRNA stability dependent 
on cis-elements on the 3’UTR of the transcripts can be pointed out. One first example 
focuses on the translational control of several mRNAs correlated with increases in their 
poly(A) tail length. This process, termed cytoplasmic polyadenylation, requires a 
polyadenylation hexanucleotide sequence (typically AAUAAA) as well as additional 
3’UTR regulatory sequences, including cytoplasmic polyadenylation elements (CPE) 
with the general structure UUUUUAU. To be functionally active, the CPE sequence 
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requires an interaction with the CPE-binding protein (CPEB), a highly conserved zinc 
finger and RNA-recognition motif (RRM)-type RNA-binding protein, necessary for the 
cytoplasmic polyadenylation-induced translation. This phenomenon was initially 
observed in Xenopus laevis oocytes where Mos, cyclin B1 and several other mRNAs 
with short tails were translationally dormant, and only upon the poly(A) tail elongation 
translation would take place (Charlesworth et al., 2004; Prasad et al., 2008). Moreover, 
CPEB has already been shown to be present in dendritic layers of the hippocampus, at 
synapses in cultured neurons and in PSDs of adult brains, which suggests that CPEB is 
not only involved in the regulation of early development, but may also be potentially 
important in the regulation of mRNAs crucial for synaptic plasticity. Accordingly, 
translation of the α-CaMKII mRNA, which contains two CPEs in its 3’UTR and is 
localized to dendrites, being crucial for the induction of LTP, has been shown to be 
regulated by CPEB (type I) via cytoplasmic polyadenylation in the synaptic region, in 
response to synaptic activity (Wu et al., 1998). Moreover, regarding AMPARs, it was 
recently demonstrated that the translation of mRNA for the GluA2 subunit is under the 
control of CPEB3, a CPEB (type 1) like protein. Richter and collaborators showed that 
CPEB3, in absence of synaptic stimulation, represses the translation of GluA2 mRNA, 
and that this repression is reverted upon NMDARs activation; also, in knockdowns for 
CPEB3, GluA2 mRNA translation is stimulated, suggesting, then, that CPEB3 may be a 
specific translational repressor for GluA2 mRNA (Huang et al., 2006). 
 Another well-characterized sequence involved in mRNA stabilization is a 50- to 
150-nucleotide sequence rich in adenosine and uridine, the so-called AU-rich element 
(ARE). These sequences are, like CPEs, located in the 3’UTR of mRNAs, however, 
they appear to have a very significant importance in the regulation of gene expression, 
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since 5-8% of human genes encode ARE-containing transcripts (Bakheet et al., 2001). 
Although AREs were originally defined as an AUUUA core associated with instability, 
it became clear over the years that ARE motifs can vary and regulate mRNA stability in 
both directions (Barreau et al., 2005). In fact, the interaction between ARE sequences 
and ARE-binding proteins can either block or enhance the recruitment of the mRNA 
decay machinery and lead to a rapid modification of gene expression (De Rubeis & 
Bagni, 2010). One of the first RNA-binding proteins known to bind AREs and to have a 
destabilizing function was the AU-binding factor 1 (AUF1), also known as hnRNP D. 
This factor was shown to modulate the decay of ARE-containing transcripts, namely the 
mRNA encoding the α2-subunit of the nitric oxide-sensitive guanylyl cyclase in the 
cerebellar granule cells: in basal conditions the transcript is bound to AUF, but upon 
NMDAR activation, AUF1 is downregulated and the α2 mRNA stabilized (Jurado et 
al., 2006). Moreover, the mRNAs for the AT1 receptor (Berger et al., 2005) and the β2-
adrenergic receptor (Tholanikunnel et al., 1999) have already been shown to be 
destabilized via AUUUUA hexamers in the 3’UTRs of the transcripts, consistent with 
ARE-like sequences. 
 One rather interesting example concerns the fragile X mental retardation protein 
(FMRP), absent in patients with Fragile X Syndrome (FXS), characterized by mental 
retardation. This protein is also an RNA-binding protein thought to regulate translation 
and subcellular localization of several transcripts (Zalfa et al., 2003). Just recently, 
however, this protein was described to have a role in the regulation of mRNA decay, 
particularly for transcripts encoding the crucial synaptic protein PSD-95 (De Rubeis & 
Bagni, 2010; Zalfa et al., 2007). The FMRP-binding site in the 3’UTR of the PSD-95 
mRNA is close to three U-rich tracts, two of them actually containing two AREs. Thus, 
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the interaction of FMRP can be preventing the action/binding of other destabilizing 
proteins and protecting the PSD-95 mRNA from decay (Zalfa et al., 2007). 
 
Zipcode binding protein1 (ZBP1) 
 Phenomena such as axonal guidance and neurite outgrowth in developing 
neurons are highly dependent on the reorganization of the cytoskeleton. Moreover, these 
phenomena are also mediated by guidance cues that induce an asymmetric targeting and 
translation of β-actin mRNA in the growth cone (Huttelmaier et al., 2005; Ming, 2006; 
Sasaki et al., 2010; Welshhans & Bassell, 2011). The Zipcode binding protein1 (ZBP1) 
is involved in the translational control and transport of β-actin mRNA.  ZBP1 contains 
two RNA recognition motifs (RRMs) and four heterogeneous ribonucleoprotein particle 
K-homology (hnRNP KH) domains, which are also known RNA-binding motifs.  
ZBP1 recruits β-actin mRNA at the site where it is transcribed, by binding to a 
conserved 54-nucleotide element, known as the ‘zipcode’, located in the 3’UTR of β-
actin mRNA (Ross et al., 1997). ZBP1 binding to the β-actin mRNA induces both 
translational silencing of the transcript and its incorporation into RNPs. Following this 
incorporation, the granules travel along dendrites through the interaction with kinesin 
motors on the microtubule-based cytoskeleton (Figure 9). Upon particular stimuli, the 
tyrosine kinase Src is able to phosphorylate ZBP1 at a key tyrosine residue that is 
required for its binding to RNA, thus relieving the repression of translation of β-actin 
mRNA once the transcript reaches its destination (Figure 9) (Huttelmaier et al., 2005). 
These sequential events provide both temporal and spatial control over β-actin 
translation and are necessary to its localization to the cell periphery.  
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Figure 9 - A model for guidance cue–induced asymmetric transport and translation of β-
actin mRNA mediated by ZBP1. Translocation of β-actin mRNA is controlled by ZBP1. 
ZBP1 associates with the β-actin mRNA in the nucleus and transports it into neuronal growth 
cones while blocking its translation initiation. A gradient of guidance cues activates yet 
unknown pathways to promote the asymmetric transport of granules containing ZBP1/β-actin 
mRNA complex into the growth cone periphery. Translation of β-actin mRNA is regulated by 
phosphorylation events. Phosphorylation of 4EBP promotes cap-dependent translation 
initiation, whereas Src kinase phosphorylates ZBP1 to release its block of translation initiation. 
Together, these cellular events lead to asymmetric distribution of newly synthesized β-actin and 
the preferential incorporation of this nascent β-actin into the cytoskeleton at one side of the 
growth cone, contributing to growth cone turning [Adapted from (Ming, 2006)]. 
 
Particularly at developing growth cones ZBP1 activity is important for 
neurotrophin-induced neurite outgrowth (Zhang et al., 2001) and its Src-dependent 
phosphorylation is required for the assymetrical and local synthesis of β-actin and 
growth cone turning and guidance, induced by external cues such as BNDF and Netrin1 
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(Leung et al., 2006; Sasaki et al., 2010; Welshhans & Bassell, 2011; Yao et al., 2006). 
Apart from its role in axonal guidance, ZBP1 also regulates the dendritic arboring of 
hippocampal neurons (Perycz et al., 2011) and localizes to dendritic spines, regulating 
their density and structure through the local translation of β-actin (Eom et al., 2003; 
Tiruchinapalli et al., 2003). Moreover, ZBP1 has also been shown to bind to the mRNA 
of cofilin, an actin-depolymerizing factor, and mediate Slit2-induced local translation 
during growth cone collapse (Piper et al., 2006). Thus, it is evident that ZBP1 plays a 
key role in the regulation of some transcripts with major importance in neuronal 
development and function, which endows ZBP1 with the potential to functionally 
regulate other transcripts. 
Furthermore, ZBP1 has already been implicated in the regulation of stability of 
several other target mRNAs, such as c-Myc, CD44, βTrCP1 and β-catenin (Gu et al., 
2008; Leeds et al., 1997; Noubissi et al., 2006; Vikesaa et al., 2006; Yisraeli, 2005) 
 
RNA-binding proteins interacting with the GluA1 mRNA 
 The importance of the regulation of mRNA stability, particularly of transcripts 
involved in synaptic plasticity, raises the tantalizing question of how does this 
regulation occur for AMPAR subunits. It is already known that transcripts of GluA1 
and GluA2 subunits localize to dendrites and specific synaptic sites and that their 
translation is controlled by paradigms of synaptic activation. But how exactly are these 
transcripts targeted and transported to dendritic spines? How is the translation of these 
transcripts repressed during their transport? What are the RNA-binding proteins either 
promoting or disrupting the stability of these mRNAs? It is already known that CPEB3 
may act as a translational repressor for the GluA2 subunit mRNA. Also, it has recently 
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been shown that retinoic acid (RA) receptor α associates with the GluA1 mRNA in 
dendrites through the 5’UTR of the transcript, repressing its translation; when RA binds 
to the receptor, its association with GluA1 mRNA is decreased, relieving the 
translational repression (Poon & Chen, 2008). However, there is no knowledge of any 
RNA-binding protein stabilizing the GluA1 mRNA. Nevertheless, in recent studies by 
Santos et al. (unpublished data) a detailed screening of the 3’UTR of the GluA1 mRNA 
was performed to find possible conserved mRNA binding motifs. Indeed, multiple 
conserved canonical cis elements were found, among which several binding sequences 
for the RNA-binding protein HuR and for other RNA-binding proteins of the embryonic 
lethal abnormal vision (ELAV) family. In fact, proteins belonging to the Hu family are 
some of the few specific proteins thought to be key regulators of mRNA turnover in the 
brain.  
Hu proteins were first identified as autoantigens in patients affected by 
paraneoplastic encephalomyelitis (Dalmau et al., 1990). Later on, after the cloning and 
sequencing of these proteins, it was found that they are human homologues of the 
Drosophila ELAV, an RNA-binding protein whose deletion results in an embryonic 
lethal abnormal vision phenotype in flies (Robinow et al., 1988). In mammals, four 
ELAV / Hu proteins have been described: HuR (also known as HuA) that is 
ubiquitously expressed, and HuB, HuC and HuD that are neuronal-specific. 
Structurally, the four proteins possess a high degree of sequence homology and they 
contain three ~ 90 amino acid-long RNA recognition motif-type (RRM) domains. These 
RRM domains are able to bind to AREs located in the 3’UTR of the transcripts. The 
first two RRMs, positioned at the N-terminal end, are separated from the third motif by 
a hinge region, thought to contain sequences that mediate the nuclear export of these 
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proteins. Indeed, Hu proteins have a relative similar expression both in the nucleus and 
the cytoplasm, which suggests that these proteins have a nucleocytoplasmic shuttling 
activity (Pascale et al., 2008). Their export to the cytoplasm may be considered a main 
prerequisite for the protective effects from mRNA decay these proteins confer to their 
cognate target mRNAs (Fan & Steitz, 1998) and thus, they can modulate the post-
transcriptional fate of mRNAs from birth to death, including the regulation of mRNA 
stability, localization and translation (Pascale et al., 2008). Experimental support for 
this supposed stabilizing function of Hu proteins has already been provided. For 
example, overexpression of HuR increases the stability of several ARE-containing 
mRNAs (Fan & Steitz, 1998), as opposed to the knockdown of the protein that 
promotes a decrease of stability in target mRNAs (Rodriguez-Pascual et al., 2000). 
Moreover, the interaction and stabilizing effect of Hu proteins has also already been 
reported for the mitogen-activated protein kinase phosphatase 1 (MKP-1) mRNA 
(Kuwano et al., 2008) and for the neuronal growth-associated protein 43 (GAP-43) 
mRNA (De Rubeis & Bagni, 2010). These recent evidences implicate a role of ELAV 
like proteins in spatial memory formation, and suggest a model in which the RNA-
binding proteins locally stabilize mRNAs whose products could be important for 
memory storage (Pascale et al., 2008). Thus, considering this and having in account the 
canonical cis binding sites for ELAV proteins found in the 3’UTR of GluA1 mRNA, we 
hypothesize that these proteins may be binding to the GluA1 transcripts, allowing their 
stabilization and preventing their decay. 
 
The objective of this introductory section was to review current knowledge 
regarding the structure and function of AMPA receptors as well as their regulatory 
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mechanisms. One of the questions in the field concerns the mechanisms that regulate 
the localized expression of AMPA receptor subunits, namely in the context of 
homeostatic synaptic plasticity. The work presented in this thesis contributes to 
elucidate some aspects of this emergent question. 
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Objectives of the present study 
 Glutamate receptors of the AMPA-type mediate most of the excitatory 
neurotransmission in the brain and play a major role in the expression of synaptic 
plasticity mechanisms that underlie learning and memory in the hippocampus (Santos et 
al., 2009). Modulation of these receptors by alterations of receptor traffic and synaptic 
insertion, mRNA stability and turnover is crucial to induce long-term changes in 
synaptic strength and efficacy (Kessels & Malinow, 2009; Sutton & Schuman, 2006). 
Even though mechanisms of AMPAR trafficking are now very well characterized, the 
molecular mechanisms regulating AMPAR transcripts are still poorly understood.  
A previous study carried out in our laboratory allowed the identification of the 
cell adhesion molecule Caspr1 has a novel interactor of the GluA1 subunit of AMPARs. 
The biochemical characterization of this molecule has shown that, besides its wide 
expression throughout dendrites, Caspr1 plays a major role in the cell surface 
expression of GluA1 as well as in its synaptic tagging. Moreover, preliminary data 
suggested an effect of Caspr1 in total levels of the GluA1 subunit, trough upregulation 
of its mRNA (Santos, 2009). Given the tantalizing hypothesis that these evidences raise 
of a novel post-transcriptional regulatory mechanism of AMPARs, it became important 
to further characterize the regulation of the GluA1 AMPAR subunit by Caspr1. 
1. Preliminary results by Sandra Santos show that Caspr1 upregulates 
GluA1 protein and mRNA levels, with no effect in GluA1 protein stability. Thus, the 
primary goal of this study is to further confirm the effect of Caspr1 in total levels of 
GluA1. Moreover, we further intend to map the molecular determinants in Caspr1 
responsible for its effect. Santos and colleagues found that the intracellular C-terminal 
domain of Caspr1 was sufficient for its effect in GluA1 expression and that deletion of 
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its proline-rich region abolished the effect of Caspr1 in GluA1 mRNA. By 
overexpressing a construct of Caspr1 that lacks its proline domain, we will evaluate the 
requirement of this region in the upregulatory effect of total protein levels of GluA1. 
2. We further hypothesize that the effect of Caspr1 in GluA1 levels 
occurs through the Caspr1-mediated activation of a signaling pathway. The proline-rich 
region of Caspr1 has been shown to interact with SH3 domains of several signaling 
molecules, particularly with that of the tyrosine kinase Src (Peles et al., 1997). Thus, we 
propose to evaluate the effect of Caspr1 in the activation of a signaling pathway 
downstream of Src, by assessing levels of phosphorylated Src as well as of 
phosphorylated ZBP1, a RNA-binding protein known to regulate mRNA translation 
upon Src-dependent phosphorylation.  
3. Given the importance of dendritically localized GluA1 transcripts to 
the expression of synaptic plasticity and the role that Caspr1 may exert in these 
mechanisms, it is of crucial importance to understand which physiological stimuli 
regulate the endogenous expression of Caspr1. Up until now, the only information 
available on the regulation of Caspr1 concerns its intracellular traffic. However, Caspr1 
effect in GluA1 levels parallels that of chronically blocking neuronal activity, which 
results in homeostatic synaptic scaling by increasing GluA1 dendritic synthesis and 
accumulation at synapses. Thus, our final aim is to evaluate how chronic blockade of 
neuronal activity with TTX, a blocker of voltage-gated sodium channels, affects the 
endogenous expression of Caspr1.  Moreover, we will evaluate if these manipulations of 
activity also activate a Src-dependent signaling pathway, which is of particular interest 
to unveil the role that Caspr1 plays in the mechanisms of homeostatic plasticity. 
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 Overall, in this project we will clarify the Caspr1-mediated molecular 
mechanisms that regulate the GluA1 subunit of AMPARs, as well as characterize 
physiological stimuli that impinge on these mechanisms. The results obtained will be 
relevant to understand how neuronal activity regulates glutamatergic synapses.  
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Materials 
Dulbecco’s modified Eagle’s medium (DMEM), Minimum essential medium 
Eagle (MEM), kynurenic acid, dithiothreitol (DTT) as well as the protease inhibitors 
phenylmethylsulfonyl fluoride (PMSF) and chymostatin, leupeptin, antipain and 
pepstatin (CLAP, stock solution 1mg/ml in dimethyl  sulfoxide – DMSO) were 
purchased from Sigma-Aldrich (Sintra, Portugal). Neurobasal medium, OptiMEM 
reduced serum medium, fetal bovine serum (FBS), horse serum (HS), penicillin-
streptomycin, trypsin and glutamine were acquired from Gibco, as part of Invitrogen 
Life Technologies (Barcelona, Spain). Lipofectamine reagent was also from Invitrogen 
Life Technologies (Barcelona, Spain) and Neurocult® SM1 neuronal supplement was 
bought from Stemcell Technologies (Grenoble, France). The enhanced 
chemifluorescence substrate (ECF) was acquired from Amersham, as part of GE 
HealthCare (Carnaxide, Portugal) and the fluorescent mounting medium was from 
DAKO (Glostrup, Denmark). Tetrodotoxin (TTX) and Bicuculline (Bic) were both 
purchased from Tocris Bioscience (Bristol, UK) and Lambda protein phosphatase (λPP) 
was acquired from New England BioLabs (through Izasa, Lisbon, Portugal). 
Polyvinylidene difluoride (PVDF) membranes were from Millipore (Madrid, Spain) and 
the BCA kit for protein quantification from Pierce, as part of Thermo Fisher Scientific 
(Rockford, Illinois, USA). The QIAGEN Plasmid mini kit was obtained from QIAGEN 
(QIAGEN GmbH, Hilden, Germany) and the PureLinkTM HiPure Plasmid Filter 
maxiprep kit was from Invitrogen Life Technologies (Barcelona, Spain). QuickChange 
II XL-site-directed mutagenesis kit was purchased from Stratagene (Cambridge, UK). 
All other reagents were from Sigma (Sintra, Portugal), BioRad (Amadora, Portugal) or 
from Merck (Darmstadt, Germany). 
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 Antibodies 
Anti-GluA1 C-terminal polyclonal (rabbit) antibody was purchased from 
Millipore (Chemicon - Massachusetts, USA), anti-GFP monoclonal (mouse) antibody 
was acquired from Roche Applied Science (Carnaxide, Portugal), anti-Caspr1 
polyclonal (rabbit) and anti-GAPDH monoclonal (mouse) antibodies were bought from 
Abcam (Cambridge, UK). Anti-Phospho Src (Tyr416) monoclonal (rabbit) and anti-Src 
monoclonal (mouse) antibodies were acquired from Cell Signaling Technologies 
(Massachusetts, USA) and anti-phospho-ZBP1 (Tyr396) polyclonal (rabbit) antibody 
was a kind gift from Dr. Gary Bassell (Emory University, Atlanta, USA). Anti-human 
transferrin receptor monoclonal (mouse) antibody was purchased from Invitrogen Life 
Technologies (Barcelona, Spain) and anti-β-tubulin monoclonal (mouse) antibody 
bought from Sigma-Aldrich (Sintra, Portugal). The alkaline phosphatase-conjugated 
anti-rabbit and anti-mouse whole secondary antibodies (from goat) were obtained from 
GE Healthcare (Carnaxide, Portugal). 
The antibodies used for immunocytochemistry are listed below. Besides the 
antibodies against GluA1, Caspr1, phospho-ZBP1 and phospho-Src mentioned above, 
anti-PSD95 monoclonal (mouse) antibody was acquired from Affinity BioReagents, as 
part of Thermo Fisher Scientific (Rockford, Illinois, USA) and anti-MAP2 polyclonal 
(chicken) antibody purchased from Abcam (Cambridge, UK). The secondary 
fluorescent antibodies anti-rabbit IgG AlexaFluor 594 (goat), anti-mouse IgG 
AlexaFluor 488 (goat) and anti-mouse IgG AlexaFluor 647 (goat) were both acquired 
from Molecular Probes, as part of Invitrogen Life Sciences (Barcelona, Spain) and 
AMCA-conjugated anti-chicken IgG (goat) secondary antibody was from Jackson 
ImmunoResearch (Porto, Portugal). 
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Constructs for transfection of hippocampal neurons and COS7 cells 
GluA1 construct was a kind gift from Dr. Juna Lerma (Instituto de 
Neurociencias de Alicante, Spain). Caspr1 was kindly provided by Dr. Catherine 
Faivre-Sarrailh (CNRS, Marseille, France) and cloned as described by Bonnon and 
colleagues (Bonnon et al., 2003). The chimeric construct Caspr1ΔPro, deleted for the 
proline-rich region of Caspr1 C-terminal, was prepared with the QuickChange II XL-
site-directed mutagenesis kit (Stratagene). Caspr1 construct was used as template and 
primers (sense primer: 5’ GGC CAC CCA TGA TTC CCA CAG GGA CCA GAA CC 
3’; antisense primer: 5’ GGT TCT GGT CCC TGT GGG AAT CAT GGG TGG CC 3’) 
were designed to match the upstream and downstream regions of the proline-rich 
domain (between nucleotides 4138 and 4251 of the Caspr1 construct), in order to 
specifically delete only this region. The constructs pEGFP-N1 (Clontech - Saint-
Germain-en-Laye, France) and pBK-CMV (Stratagene, Cambridge, UK) were used as 
controls for transfection. All DNA constructs were verified by DNA sequencing.  
 
COS7 cells culture – maintenance and transfection 
COS7 cells, a cell line derived from immortalized kidney cells of the African 
green monkey, were maintained at 37°C in a humidified incubator with 5% CO2 / 95% 
air, incubated in Dulbecco’s modified Eagle’s medium, supplemented with 10% fetal 
bovine serum, 1% penicillin/streptomycin and 44mM NaHCO3 at pH 7.2, to a 
subconfluence of 60-80% and diluted 1:5 every three days.  
COS7 cells were transiently transfected with lipofectamine reagent as follows: 
lipofectamine was diluted in OptiMEM reduced serum medium, to which a total of 
12µg of plasmid DNA, previously diluted in OptiMEM to an equivalent volume, was 
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added. The DNA-lipofectamine mix was then gently vortexed for 2-3 seconds and 
incubated at room temperature for 20 minutes to allow the formation of complexes. 
Precipitates were then added to cells cultured on 10cm2 wells and incubated for 5 hours 
at 37°C. After the transfection period, fresh culture medium was added to the culture 
and cells were returned to the incubator and allowed to express the transfected 
constructs for 48 hrs. 
 
Hippocampal cultures (high density cultures)  
Primary cultures of rat hippocampal neurons were prepared from the 
hippocampus of E18-E19 Wistar rat embryos. After dissection, hippocampi were treated 
for 15 min at 37°C with trypsin (0.06%), in Ca2+- and Mg2+-free Hank’s balanced salt 
solution (HBSS: 5.36mM KCl, 0.44mM KH2PO4, 137mM NaCl, 4.16mM NaHCO3, 
0.34mM Na2HPO4.2H2O, 5mM glucose, 1mM sodium pyruvate, 10mM HEPES and 
0.001% phenol red). To stop trypsin activity, hippocampal cells were washed with 
HBSS containing 10% fetal bovine serum, and then washed again with HBSS to remove 
serum and avoid glia growth. Finally, hippocampal cells were transferred to Neurobasal 
medium (supplemented with SM1 neuronal supplement (1:50 dilution), 25µM 
glutamate, 0.5mM glutamine and 0.12mg/ml gentamycin), mechanically dissociated and 
then plated at a density of 8.9 x 105 cells/cm2 in 6-well plates, coated with poly-D-lysine 
(0.1mg/ml). Cultures were maintained at 37°C in a humidified incubator of 5% CO2 / 
95% air, for seven or fourteen days. 
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Hippocampal Banker cultures (low density cultures) 
Banker cultures were prepared from hippocampal neurons as previously 
described by Banker and colleagues (Banker & Goslin, 1998). Briefly, hippocampal 
neurons, dissected from E18 rat embryos and dissociated using trypsin (0.25%) and 
trituration, were plated in neuronal plating medium (MEM supplemented with 10% 
horse serum, 0.6% glucose and 1mM pyruvic acid) onto poly-D-lysine-coated 
coverslips in 60mm culture dishes, at a final density of 1-5 x 105 cells/dish. After 2-4 
hrs, coverslips were flipped over an astroglial feeder layer in Neurobasal medium 
(supplemented with SM1 neuronal supplement (1:50 dilution), 25µM glutamate, 0.5mM 
glutamine and 0.12mg/ml gentamycin). Wax dots on the neuronal side of the coverslips 
allowed the physical separation of neurons from the glia, despite neurons growing face 
down over the feeder layer. To further prevent glia overgrowth, neuron cultures were 
treated with 5µM cytosine arabinoside after 3 days in vitro (DIV). Cultures were 
maintained at 37°C in a humidified incubator of 5% CO2 / 95% air, for up to 3 weeks. 
 
Transfection of hippocampal neurons – calcium phosphate protocol 
Constructs were recombinantly expressed in both high- and low-density cultures 
of hippocampal neurons at DIV7 using a calcium phosphate transfection protocol 
adapted from Jiang and collaborators (Jiang et al., 2004). Plasmid DNAs were diluted in 
Tris-EDTA transfection buffer (10mM Tris-HCl, 2.5mM EDTA, pH 7.3). A CaCl2 
solution (2.5M in 10mM HEPES) was added, drop-wise, to the DNA solution to a final 
concentration of 250mM CaCl2, and added to an equivalent volume of HEPES-buffered 
solution (274mM NaCl, 10mM KCl, 1.4mM Na2HPO4, 11mM dextrose and 42mM 
HEPES, pH 7.2). The final transfection solution was then gently mixed for 2-3 sec and 
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incubated, protected from light, at room temperature for 30 min to allow the formation 
of precipitates, and vortexed every 5 min. Precipitates were added, drop-wise, to DIV7 
hippocampal neurons and cultures were incubated at 37°C for 1-3 hrs in the presence of 
kynurenic acid (2mM in Neurobasal medium). After this period, transfection medium 
was removed and cells were incubated at 37°C for 20 min with culture medium 
containing kynurenic acid, slightly acidified with HCl. Finally, reserved, conditioned 
medium was added to the cells, which returned to the incubator to allow expression of 
the transfected constructs, until DIV15. 
 
Stimulation of primary hippocampal cultures  
To look for physiological stimuli regulating the expression of Caspr1, activity in 
hippocampal neurons was either blocked or enhanced with tetrodotoxin (TTX) or 
bicuculline (Bic), respectively. Hippocampal neurons at DIV14 (from primary high 
density cultures) or at DIV20 (hippocampal neurons from Banker cultures) were 
stimulated for 24 hrs, at 37°C, in conditioned medium. TTX was used at 1µM (stock 
solution – 2mM in aqueous solution) and Bic was used at 40µM (stock solution – 
40mM in DMSO). After 24 hrs, cells were either extracted for Western blot analysis 
(high density cultures) or fixed for immunocytochemistry experiments (Banker 
cultures).  
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COS7 cells and hippocampal neurons total extracts 
Total extracts of COS7 cells and high density hippocampal cultures were 
prepared for Western Blot (WB) analysis. Total extracts of COS7 cells were prepared at 
48 hrs after transfection and total cell extracts of hippocampal neurons were prepared at 
DIV15. Cells were washed once with cold phosphate buffered saline (PBS – 137mM 
NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4) and then ice-cold lysis 
buffer RIPA (150mM NaCl, 50mM Tris-HCl (pH 7.4), 5mM EGTA, 1% Triton, 0.5% 
DOC and 0.1% SDS at a final pH 7.5, with phosphatase inhibitors (1mM sodium 
orthovanadate (Na3VO4) and 50mM sodium fluoride (NaF)) supplemented immediately 
before use with 1mM DTT and a cocktail of protease inhibitors (200µM PMSF and 
1µg/ml each of chymostatin, leupeptin, antipain and pepstatin) was added to the cells, 
which were then scraped. The lysates obtained were sonicated with an ultrasonic probe, 
on ice, for 30 sec (6 pulses of 5 sec each). After centrifugation at maximum speed for 10 
min at 4°C, cell debris and insoluble material were discarded and the supernatant 
submitted to protein quantification by the BCA method (Pierce). The protein was 
aliquoted and frozen at -20°C, until needed.  
For the dephosphorylation assays using the Lambda protein phosphatase (λPP), 
total cell extracts of hippocampal neurons at DIV15 were washed in ice-cold PBS and 
extracted with the lysis buffer RIPA without phosphatase inhibitors (sodium 
orthovanadate and sodium fluoride). Lysates were then solubilized and protein was 
quantified, as described above. Approximately 150µg of protein of each sample to be 
dephosphorylated were incubated with 2µl of λPP in 1xNEBuffer for protein 
metallophosphatases (PMP) (50mM HEPES, 100mM NaCl, 2mM DTT, 0.01% Brij 35, 
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pH 7.5) supplemented with 1mM MnCl2, for 2 hrs at 30°C. Following this period, 
samples were denatured at 95°C for 5 min, aliquoted and stored at -20°C, until needed. 
  
Gel electrophoresis and Western blot 
Samples were denatured at 95°C for 5 min and resolved by SDS-PAGE in Tris-
glycine-SDS (TGS) buffer (25mM Tris, 192mM glycine, 0.1% SDS, pH 8.3) in 7.5% 
polyacrylamide gels 1.5mm thick at 60-80V. Approximately 130-150µg of each sample 
was loaded to the gels. For Western blot analysis, proteins were transferred onto a 
PVDF membrane by electroblotting overnight at 40V and 4°C. Membranes were 
washed once with 0.1% Tween 20 in Tris-buffered saline (TBS) (20mM Tris, 137mM 
NaCl, pH 7.6 (TBS-T)) and then blocked for 1 hr at room temperature either with 5% 
(w/v) BSA or 5% (w/v) non-fat dry milk in TBS-T. Membranes were washed again 
once with TBS-T and probed during 1 hr, at room temperature, or overnight, at 4°C, 
with the primary antibody diluted in 5% BSA in TBS-T (the antibody against total Src 
was prepared in 5% non-fat milk in TBS-T and all washes were done with 0.5% milk in 
TBS-T). The following dilutions of primary antibodies were used: anti-GluA1 1:1000, 
anti-Caspr1 1:250, anti-phospho-ZBP1 1:500, anti-phospho-Src 1:1000, anti-Src 
1:1000, anti-GFP 1:1000, anti-human transferrin receptor 1:1000, anti-GAPDH 1:20000 
and anti-β-tubulin 1:25000.  
Following several washes with TBS-T, the membranes were incubated for 1 hr, 
at room temperature, with alkaline phosphatase-conjugated IgG secondary antibody 
(1:20000 - anti-rabbit or anti-mouse, depending on the primary antibody host-species). 
Membranes were then washed again and immunostaining was resolved with the 
enhanced chemifluorescence (ECF) substrate for a maximum of 5 min or until protein 
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bands were visible and membranes were scanned on a VersaDoc Imaging System 
(Model3000 – BioRad, Amadora, Portugal). Bands corresponding to the proteins of 
interest were quantified using Image J 1.43 software and normalized with the loading 
controls (Gapdh, Human transferrin receptor or β-tubulin) indicated in figure captions.  
 
 Stripping and reprobing 
The first antibodies to be probed in membranes were the ones against phospho-
ZBP1 and phospho-Src. In order to reprobe the membranes for the other antibodies, 
membranes were re-activated and ECF was removed with a solution of 40% (v/v) 
methanol for 30 min. After a 5 min wash with distilled water, membranes were stripped 
for 10 min with 0.2M NaOH and washed once again with water. Membranes were 
blocked for 1 hr, at room temperature, with 5% BSA or 5% non-fat dry milk in TBS-T, 
incubated in the primary and secondary antibodies and resolved, as previously 
described.  
 
Immunocytochemistry 
Hippocampal neurons from Banker cultures at DIV15 or DIV21 were fixed for 
15 min, at room temperature, in 4% sucrose / 4% paraformaldehyde in PBS, washed 3 
times in PBS and permeabilized with 0.25% Triton X-100 in PBS for 5 min, at 4°C. 
Neurons were then incubated in 10% (w/v) BSA in PBS for 30 min, at 37°C to block 
nonspecific staining, and incubated with primary antibodies, diluted in 3% BSA in PBS, 
overnight at 4°C. The following dilutions of primary antibodies were used: anti-GluA1 
C-terminal 1:100, anti-Caspr1 1:50, anti-phospho-ZBP1 1:250, anti-phospho-Src 1:250, 
anti-PSD95 1:300 and anti-MAP2 1:10000.  
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After several washes with PBS to remove primary antibodies, cells were 
incubated with the appropriate secondary antibodies (anti-mouse IgG AlexaFluor 488 
(1:500), anti-rabbit IgG AlexaFluor 594 (1:500), anti-mouse IgG AlexaFluor 647 
(1:500) or AMCA-conjugated anti-chicken IgG (1:200)), diluted in 3% BSA in PBS, for 
1 hr at 37°C. Coverslips were then washed with PBS and mounted using fluorescent 
mounting medium from DAKO. Preparations were cured overnight at 4°C, protected 
from light, sealed with nailpolish and kept at 4°C until microscopy analysis.  
 
Fluorescence microscopy and quantification 
Fluorescent imaging was performed on a Zeiss Axiovert 200M inverted 
microscope, with an AxioCam HRm camera and with AxioVision 4.8 software. Images 
were acquired with a Plan-Neofluor 63 x oil objective (numerical aperture 1.4). In 
single experiments, cells were cultured and stained simultaneously and imaged using 
identical settings. In experiments where cells had been previously transfected, fields for 
imaging were chosen by the GFP channel, for the presence of transfected, GFP-positive, 
neurons.  
GluA1, phospho-ZBP1 and phospho-Src clustering was analyzed and quantified 
with Image J 1.43 analysis software. Dendrites were randomly chosen from exported 
16-bit images and their lengths determined. Selected dendrites had similar thickness and 
appearance and their selection was carried out in MAP2 images, without observing the 
labeling of interest. The GluA1, phospho-ZBP1 and phospho-Src signals were analyzed 
after thresholds were set, such that recognizable clusters were included in the analysis, 
and the background intensity of each image was subtracted. Synaptic GluA1, phospho-
ZBP1 or phospho-Src puncta were selected by colocalization with PSD95. Regions 
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around thresholded puncta were overlaid as a mask in the PSD95 channel, and 
colocalization was determined. To evaluate the percentage of synapses containing 
phospho-ZBP1 or phospho-Src clusters, PSD95 puncta were thresholded and overlaid as 
a mask in phospho-ZBP1 or phospho-Src channels to determine colocalization. 
Per each selected cell, intensity, area and number of total and synaptic puncta 
per dendritic length was determined. The values obtained per cell were normalized 
against the control mean of that single experiment. Measurements were performed in 
three independent experiments (except for phospho-Src, with a single experiment) and 
at least 12 cells per condition were analyzed for each preparation.  
 
Statistical analysis  
Graphs and statistical analysis were performed using Graph Pad Prism 5 
software. Results are presented as normalized means ± S.E.M. and statistical analysis 
was assessed by unpaired t-test or one-way ANOVA analysis of variance followed by 
the Dunnett’s post test, as indicated in figure captions.  
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Caspr1 overexpression increases total protein levels of GluA1 in COS7 cells and in 
hippocampal neurons in culture  
Throughout the last years, many efforts have been made to understand the 
molecular mechanisms underlying synaptic plasticity, the cellular correlate of learning 
and memory. These two phenomena rely on the ability of the mammalian brain to 
undergo experience-based adaptations that occur at the level of glutamatergic synapses, 
which become stronger or weaker in response to specific patterns of activity (Shepherd 
& Huganir, 2007). Glutamate receptors of the AMPA-type mediate most of the fast 
excitatory synaptic transmission in the brain and postsynaptic alterations in AMPAR 
number or function, through tight regulation of receptor trafficking, are crucial to induce 
long-term changes in synaptic strength and efficacy (Kessels & Malinow, 2009; 
Malinow & Malenka, 2002; Newpher & Ehlers, 2008; Song & Huganir, 2002). 
Moreover, AMPARs are not static components of the synaptic membrane but, instead, 
they are continuously being delivered and removed in and out of synapses in response 
to neuronal activity.  Indeed, synaptic plasticity mechanisms involve the modulation of 
AMPARs that are already expressed at the synapse and/or the rapid recruitment of new 
AMPARs to the synaptic membrane to alter receptor number and complement (Santos 
et al., 2009). During long-term potentiation (LTP), an increase in AMPA-mediated 
currents occurs following the activity-dependent recruitment and insertion of AMPARs 
into the postsynaptic membrane, whereas long-term depression (LTD) occurs through 
the internalization of AMPARs, culminating in a decreased synaptic function of the 
receptors (Malenka & Bear, 2004). Thus, it is evident that these phenomena of synaptic 
plasticity require an exquisite regulation of the trafficking of AMPARs and of the rate 
of their synaptic insertion or removal. Events such as the regulation of the stoichiometry 
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of receptor subunits, RNA processing events, posttranslational modifications, such as 
phosphorylation, and, particularly, interacting partners of AMPARs, are major 
contributors to the regulation of AMPAR traffic and localization.  
AMPAR subunits, through their C-terminus, are able to bind to a variety of 
accessory and scaffolding proteins. These interacting proteins form highly dynamic 
macromolecular complexes thought to anchor AMPARs to the synaptic membrane, and 
ultimately contributing to the strengthening of synapses. Moreover, it is now well 
established that the final steps in the synaptic delivery of AMPARs are subunit-specific, 
that is, they highly depend on AMPAR subunit composition and, specifically, on cis-
signals contained within their intracellular C-termini (Passafaro et al., 2001; Shi et al., 
2001). Thus, in the search for these AMPAR binding partners, the cytosolic carboxy 
terminal of AMPAR subunits has been intensively studied, mainly using yeast two-
hybrid and GST pull-down assays. Some of the already known interactors of AMPARs 
include several PDZ-domain containing proteins, such as SAP97, the first protein 
reported to directly interact with the GluA1 subunit of AMPARs (Leonard et al., 1998). 
Protein 4.1N is another well described GluA1-interacting protein that serves as an 
adapter to link GluA1 to the actin cytoskeleton in spines, thus stabilizing the surface 
expression of GluA1-containing AMPARs (Shen et al., 2000). Several transmembrane 
proteins, such as stargazin, belonging to the transmembrane AMPAR regulatory 
proteins (TARPs) family, have also been characterized as auxiliary subunits of 
AMPARs. TARPs coassemble with AMPARs and promote their surface expression and 
clustering at excitatory synapses, through direct binding to PSD-95 (Chen et al., 2000; 
Sumioka et al., 2010; Ziff, 2007). More recently, proteins of the cornichon family were 
identified as novel transmembrane interactors of AMPARs and are thought not only to 
increase surface expression of AMPARs but also to alter channel gating properties 
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(Schwenk et al., 2009). Although the composition of this intricate protein network that 
binds to AMPARs is yet not fully characterized, the large collection of AMPAR 
partners identified so far has already started to shed a light on the details of AMPAR 
trafficking and surface expression and has given some insight on the roles of individual 
interactors in these mechanisms (Bredt & Nicoll, 2003; Henley, 2003).  
Nevertheless, in order to further understand the mechanisms governing AMPAR 
trafficking and unravel new interactors of these receptors, a recent proteomic study was 
carried out in our laboratory. By combining affinity purification of protein complexes 
with mass spectrometric analysis of their composition, the identification of several 
novel binding partners for AMPARs was possible (Santos et al., 2010). Several 
cytoskeleton proteins, such as spectrin and α-internexin; motor proteins, such as myosin 
9 and Va; RNA processing proteins, such as heterogeneous nuclear ribonucleoprotein M 
and RNA helicases, among others, were some of the identified AMPAR interacting 
proteins. The glycosylphosphatidyl inositol (GPI)-anchored Contactin1, a cell adhesion 
molecule previously implicated in synaptic plasticity (Murai et al., 2002), was also 
found to interact with AMPARs. However, one of the most interesting findings in this 
proteomic screening was the identification of a novel transmembrane protein, Contactin 
associated protein 1 (Caspr1), as an interactor of AMPARs. This cell adhesion 
molecule, also known as paranodin, together with Contactin1, exerts important 
functions in the process of axonal myelination, particularly at septate-like paranodal 
junctions (Einheber et al., 1997). With an extracellular architecture similar to that of 
neurexins, it is the intracellular C-terminal tail of Caspr1 that possesses particular 
interest since it contains a region for binding of FERM domains (like protein 4.1N) and 
a sequence rich in proline residues, with potential binding sites for SH3 domains (Peles 
et al., 1997).  
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The previous evidences implicating Contactin1 in synaptic plasticity, the 
localization of the complex Caspr1 / Contactin1 in synaptic sites throughout dendrites 
of CA1 hippocampal neurons (Murai et al., 2002), the fact that both proteins appear to 
be binding partners of AMPARs and, also, the complex architecture of Caspr1, typical 
of molecules involved in protein-protein interactions, led Santos and colleagues to 
perform the biochemical characterization of the interactions of Caspr1 and Contactin1 
with AMPARs, and understand the role of these novel interactors in the trafficking of 
the receptors. Immunoprecipitation experiments and pull-down assays further confirmed 
the interaction of Caspr1 and Contactin1 with AMPARs, particularly with the GluA1 
and GluA4 subunits, both in a heterologous system and in rat brain synaptosomes. Also, 
biotinylation assays showed that overexpression of Caspr1 and Contactin1 leads to an 
increase in GluA1 cell surface levels. Furthermore, in addition to affecting AMPAR 
traffic, preliminary results indicated that Caspr1 slightly increases GluA1 total protein 
levels, without affecting protein stability. This result prompted the idea that the increase 
in GluA1 levels could be due to an effect of Caspr1 in GluA1 mRNA levels, which was 
confirmed by quantitative real-time PCR experiments, suggesting a role for Caspr1 in 
the stability of GluA1 mRNA (Santos, 2009).  
In the course of the experiments mentioned above and given the tantalizing 
hypothesis that they raise of a possible novel mechanism of regulation for AMPARs, it 
became important to further confirm the effect of Caspr1 in the total levels of GluA1, 
which was, then, the primary objective of the present study. To achieve this, a 
heterologous system was firstly used to express GluA1 in COS7 cells, alone or together 
with Caspr1. At 48 hrs post-transfection, total cell extracts were obtained and the total 
levels of GluA1 were assessed by western blot analysis (Figure 10A). 
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Figure 10 – Caspr1 increases GluA1 total protein levels in transfected COS7 cells and 
hippocampal neurons. (A) Cultured COS7 cells were co-transfected either with GluA1 + CMV 
empty vector + GFP or with GluA1 + Caspr1 + GFP, as indicated. Cells were allowed to 
express the constructs for 48 hrs, after which total cell extracts were obtained and GluA1 and 
Caspr1 levels assessed by western blot. (B) High-density cultured hippocampal neurons were 
transfected at DIV7 with GFP (Control) or with GFP + Caspr1, as indicated. Cells were allowed 
to express the proteins until DIV15, when total cells extracts were obtained and GluA1 and 
Caspr1 levels assessed by western blot. (A-B) Results are presented as means ± S.E.M. when 
compared to control and normalized to the loading control GAPDH. Statistical analysis was 
determined by the unpaired t-test, (A) *p<0.05 and (B) **p<0.01. 
 
 Indeed, when GluA1 is co-transfected with Caspr1 in COS7 cells, there is a 
significant increase of 83 ± 29 % (to 183 ± 29 % of control, *p<0.05) in GluA1 total 
protein levels, compared to control values (Figure 10A). In order to confirm if a similar 
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effect can be observed in a neuronal system, Caspr1 was overexpressed in hippocampal 
neurons in culture, by transfecting high-density cultures at DIV7, using the calcium 
phosphate method. At DIV15, total extracts were obtained and GluA1 levels were 
assessed by western blot (Figure 10B). According to the results obtained in the 
heterologous system, overexpression of Caspr1 in hippocampal neurons led to a small 
but statistically significant increase of 16 ± 5 % (**p<0.01) in GluA1 total protein 
levels, when compared to control values (Figure 10B).  
When comparing the results obtained in COS7 cells and hippocampal neurons, 
overexpression of Caspr1 in hippocampal neurons leads to a consistent but smaller 
upregulation of GluA1 levels when compared to the effect observed in COS7 cells, even 
though results are statistically significant in both situations. This discrepancy may be 
explained by the fact that Caspr1 is endogenously expressed in neurons, and therefore 
overexpression of Caspr1 in the neuronal system is not as efficient in promoting GluA1 
upregulation as in COS7 cells, where endogenous Caspr1 is absent. The other aspect to 
be taken into account is differences in the transfection efficiency between both 
expression systems. COS7 cells have a higher rate of transfection, since they are more 
easily transfected and more resistant to this process, with little consequent cellular 
death. Hippocampal neurons, however, are not only more difficult to transfect but also 
very sensitive to transfection protocols. Thus, using a calcium phosphate method will 
possibly prevent a higher percentage of cell death following transfection but it will not 
be as efficient as other protocols. Having this into account, one has to consider that total 
cell lysates of high-density-cultured hippocampal neurons are probably extracted from a 
majority of non-transfected cells, which, when assessing GluA1 levels by western blot, 
will possibly dilute the effect of Caspr1 overexpression in upregulating total levels of 
the GluA1 subunit. One possible alternative to overcome this problem is to perform 
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immunocytochemistry experiments and evaluate the effect of Caspr1 in the GluA1 
subunit at the single cell level, exclusively from transfected cells. To achieve this, 
Banker type low density cultured hippocampal neurons were transfected at DIV7 either 
with GFP (control) or GFP + Caspr1, using the calcium phosphate protocol. Cells were 
allowed to express the proteins until DIV15, when they were fixed and double-labeled 
with antibodies for the GluA1 subunit as well as for the post-synaptic marker PSD-95. 
To specifically evaluate the effect of Caspr1 overexpression in GluA1 levels, fields for 
imaging were chosen by the GFP channel, for the presence of transfected, GFP-positive, 
neurons (Figure 11).  
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Figure 11 – Caspr1 slightly increases intensity, area and number of total and synaptic 
GluA1 puncta in transfected hippocampal neurons. (A) Primary hippocampal neurons from 
low-density Banker cultures were transfected at DIV7 with GFP (Control) or with GFP + 
Caspr1, as indicated. Cells were allowed to express the proteins until DIV15, after which they 
were fixed and immunolabeled with antibodies for GluA1 (red) and PSD-95 (blue). Images 
were taken using a Zeiss Axiovert 200 fluorescent microscope. Dendrites were visualized via 
MAP2 staining and fields for imaging were chosen by the GFP channel, for the presence of 
transfected, GFP-positive, neurons. Scale bar: 20µm; Scale bar (crops): 5µm. Arrows indicate 
colocalization with PSD-95 puncta. (B - C) Quantification of the results shown in (A). GluA1 
clustering was analyzed and quantified with Image J 1.43 analysis software. Dendrites were 
randomly chosen and their lengths determined. (B) Total GluA1 signal was analyzed after 
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thresholds were set, such that recognizable clusters were included in the analysis, and the 
background intensity of each image was subtracted. (C) Synaptic GluA1 puncta were selected 
by colocalization with PSD-95 (see arrows). (B-C) Per each selected cell, intensity, area and 
number of total (B) and synaptic (C) puncta per dendritic length was determined. Measurements 
were performed in three independent experiments with at least 12 cells per condition, and values 
obtained per cell were normalized against the control mean of that single experiment. Results 
are presented as means ± S.E.M. Statistical analysis was determined by the unpaired t-test, 
although no statistical significance was achieved, ns - p>0.05. 
 
 Surprisingly, when analyzing GluA1 clustering from single transfected cells, the 
expected upregulatory effect of Caspr1 in GluA1 levels was not evident and a more 
robust response was expected (Figure 11). Overexpression of Caspr1 was only able to 
slightly increase in 10 ± 6 % the total intensity of GluA1 puncta. A similar effect was 
obtained for the total area and number of GluA1 puncta (109 ± 5 % and 110 ± 5 % of 
control, respectively) (Figure 11B). Moreover, Caspr1 was not able to significantly 
increase the intensity, area or number of synaptic (assessed by PSD-95 colocalization) 
GluA1 clusters (109 ± 6 %, 109 ± 5 % and 110 ± 5 % of control, respectively), although 
there is a clear upregulatory tendency (Figure 11C). Indeed, despite the fact that these 
results do not reach statistical significance, they are comparable to what was observed 
by western blot analysis, since a 10 to 16 % increase in GluA1 levels was obtained in 
both experiments.   
Altogether, these results are in accordance to what was presented by Santos and 
colleagues. In both COS7 cells and hippocampal neurons, Caspr1 appears to be 
upregulating total protein levels of the GluA1 subunit. Analyzing the results at the 
single cell level, there appears to be an incremental tendency in GluA1 levels when 
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Caspr1 is overexpressed, in the intensity, area and number of GluA1 puncta, although 
values do not reach statistical significance. Regarding synaptic levels of the GluA1 
subunit, the results observed are far from what was expected. Santos and colleagues 
reported a marked increase in the cell surface expression of GluA1 when Caspr1 is 
overexpressed, suggesting a role for this protein in the regulation of AMPAR traffic 
(Santos, 2009). Thus, it would be expectable that, when overexpressing Caspr1, a 
significant increase in synaptic GluA1 puncta was observed, which did not occur. Still, 
Caspr1 was able to slightly increase this synaptic subset of GluA1 clusters, and perhaps 
a significant difference in results can be achieved if more experiments are performed. 
Hence, these results, together with the ones presented by Santos, endow Caspr1 with 
particular importance in regard to the regulation of AMPARs, proposing a novel player 
to control their expression and trafficking. 
Nevertheless, the mechanisms underlying this effect of Caspr1 in GluA1 levels 
are still unknown. Given the overall architecture of Caspr1, composed of domains 
typically involved in protein-protein interactions, it is a natural assumption to think that 
the interaction of Caspr1 with GluA1 and its upregulatory effect in this AMPAR subunit 
are mediated by one of its regions. The extracellular domain of Caspr1 is similar to the 
extracellular structure of neurexins, a family of highly polymorphic cell surface 
molecules (Peles et al., 1997). It contains a discoidin domain next to its N-terminal, 
several sequences with homology to the extracellular matrix proteins laminin A, agrin, 
slit and perlecan, two epidermal growth factor (EGF)-like regions, a central fibrinogen 
domain and several PGY (proline – glycine – tyrosine) repeats (Figure 6). Its 
intracellular C-terminal tail, on the other hand, possesses particular interest, since it 
contains a juxtamembrane region for the binding of molecules containing FERM 
domains, such as protein 4.1N (or 4.1B), schwannomin and β-integrin1 (Denisenko-
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Nehrbass et al., 2003a; Denisenko-Nehrbass et al., 2003b), and a sequence rich in 
proline residues, with at least one canonical SH3-domain binding site, which suggests 
the interaction of Caspr1 with several molecules typically involved in signaling 
pathways (Peles et al., 1997). Still, despite the knowledge on its architecture, very little 
is known about Caspr1 and its interactors: extracellularly, Contactin1 is the only known 
partner of Caspr1, and its intracellular partners, despite several already described, are 
very poorly characterized. Given this, in order to shed some light onto the mechanism 
underlying the effect of Caspr1 in GluA1 levels, Santos and colleagues firstly sought to 
dissect the region of Caspr1 involved in the interaction with AMPAR subunits. By 
expressing the C-terminal of Caspr1 as a GST-fusion protein, they were able to pull-
down GluA1, GluA2 and GluA4 subunits from rat cerebellum lysates and, thus, 
confirming a role for the C-terminal region of Caspr1 in the interaction with AMPARs. 
However, they also showed that, besides the C-terminal region of both AMPAR 
subunits and Caspr1, other molecular determinants must be involved in their interaction, 
since immunoprecipitation of a truncated form of GluA1, lacking its intracellular C-
terminal, was able to co-immunoprecipitate Caspr1, thus, suggesting that the C-terminal 
tail of Caspr1 is not essential for the interaction with GluA1, and that other regions of 
the molecule are also involved (Santos, 2009). Interestingly, similar evidences have 
been described for the interaction between AMPARs and stargazin, with both 
extracellular and intracellular regions of stargazin participating in the interaction and 
differentially controlling AMPAR channel properties and trafficking, respectively 
(Tomita et al., 2005a; Tomita et al., 2004). 
Despite defining that both extracellular and intracellular regions of Caspr1 are 
involved in the interaction between this protein and AMPARs, the previously described 
evidences by Santos and colleagues are not clear regarding the actual region responsible 
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for the upregulatory effect in GluA1 levels. Accordingly, further experiments were 
performed indicating a prominent role for the intracellular C-terminal domain of Caspr1 
in increasing GluA1 subunit. Electrophysiology studies indicated that the C-terminal 
domain of Caspr1 increases the amplitude of AMPAR-mediated miniature excitatory 
postsynaptic currents (mEPSCs), which suggests that the intracellular region of Caspr1 
increases the traffic of AMPARs to synapses. Moreover, overexpression of the same 
construct encoding the C-terminal domain of Caspr1 led to a significant increase both in 
GluA1 total protein levels, in hippocampal neurons, and mRNA levels in COS7 cells, 
further confirming the role of the C-terminal tail of Caspr1 in the overall upregulatory 
effect in the GluA1 subunit (Santos, 2009). 
In the present study, we sought to further explore and map the molecular 
determinants responsible for the effect of Caspr1 in the GluA1 subunit. Based on the 
evidences presented by Santos and colleagues, the intracellular C-terminal region of 
Caspr1 assumes an important role in the regulation of AMPARs. As previously 
described, this intracellular domain of Caspr1 presents a rather interesting architecture, 
common in molecules involved in protein-protein interactions. Its membrane proximal 
intracellular region comprises a short peptide with a motif conserved in glycophorin C, 
neurexin IV and paranodin (GNP motif) and is capable to interact with protein 
encompassing FERM domains (Denisenko-Nehrbass et al., 2003a; Denisenko-Nehrbass 
et al., 2003b). Interestingly, the GNP motif is also found in proteins such as SynCAM, a 
protein capable to drive synaptic assembly (Biederer et al., 2002). In Caspr1, this GNP 
motif allows its interaction with the protein 4.1B, a major physiological partner of 
Caspr1 at paranodes. This association could provide a link between intercellular 
complexes and the cytoskeleton, allowing for the stabilization of Caspr1 at the plasma 
membrane (Gollan et al., 2002; Menegoz et al., 1997). One possible model is that 
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Caspr1, through binding to proteins containing the 4.1 domain and which serve as actin 
adapters, may indirectly modulate the interaction of AMPAR subunits with specialized 
components of the cytoskeleton, eventually present at the postsynaptic scaffold, and 
thus, contribute to the stabilization of receptors at the cell surface and to their synaptic 
targeting. Curiously, the synaptic targeting of the GluA1 subunit by SAP97 has already 
been described to be dependent on the interaction of SAP97 with the protein 4.1 
(Rumbaugh et al., 2003). As for the tail of Caspr1 C-terminal domain, it contains a 
sequence rich in proline residues that comprises a SH3-domain binding site, which 
suggests the interaction of Caspr1 with several molecules typically involved in signaling 
pathways (Peles et al., 1997). Indeed, the proline-rich region of Caspr1 has already been 
found to selectively interact with the SH3 domains of Src, Fyn, PLCγ and the p85 
subunit of PI3K. Moreover, the interaction between Caspr1 and Src was further 
confirmed when both proteins were exogenously expressed in co-transfected COS7 
cells: immunoprecipitation with several c-Src-specific antibodies was able to co-
precipitate Caspr1 from lysates of transfected cells (Peles et al., 1997). Nevertheless, the 
physiological relevance of the described interactions remains unclear.  
Thus, having in consideration all the results suggesting an important role for the 
C-terminal of Caspr1 in the overall upregulation of GluA1 levels and all the evidences 
regarding possible binding partners for Caspr1 that can be mediating this effect, we 
decided to further dissect the molecular determinants of Caspr1 responsible for its effect 
on GluA1 levels. For that, cultured COS7 cells were transfected either with GluA1 
alone, together with the full-length Caspr1 construct or together with a deletion mutant 
of Caspr1, designed to selectively lack its intracellular C-terminal proline-rich region 
(Caspr1ΔPro). Cells were allowed to express the proteins for 48 hrs, after which total 
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cell extracts were obtained and total levels of GluA1 assessed by western blot analysis 
(Figure 12).     
 
Figure 12 – The proline (PRO)-rich region of the C-terminal intracellular domain of 
Caspr1 plays a role in upregulating GluA1 total protein levels, in COS7 cells. Cultured 
COS7 cells were co-transfected either with GluA1 + CMV empty vector + GFP, GluA1 + 
Caspr1 (full-length) + GFP or with GluA1 + Caspr1ΔPro + GFP, as indicated. Cells were 
allowed to express the constructs for 48 hrs, after which total cell extracts were obtained and 
GluA1 levels assessed by western blot. Values corresponding to GluA1 levels were normalized 
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to the loading control Transferrin R (human transferrin receptor) and the results presented 
correspond to a single independent experiment.  
 
 As expected, the exogenous expression of Caspr1 in GluA1-co-transfected 
COS7 cells resulted in a marked increase of approximately 94% in GluA1 total protein 
levels, when compared to control values (Figure 12). However, when COS7 cells were 
co-transfected with the deletion mutant for the proline-rich region of Caspr1 
(Caspr1ΔPro), designed to specifically lack this region, the upregulatory effect of 
Caspr1 in GluA1 total proteins levels was completely lost, with GluA1 levels 
decreasing to values similar to the control situation (88% of control) (Figure 12). 
Despite the fact that these results are very preliminary (they are the result of a single 
independent experiment), they are extremely interesting. The abolishment of the 
upregulatory effect in GluA1 levels when the proline-rich region is deleted from the 
intracellular C-terminal of Caspr1 indicates that this domain may be necessary for 
Caspr1 to exert its effect. Accordingly, preliminary results obtained in our laboratory 
further confirm this possibility. GluA1 mRNA levels are significantly upregulated when 
COS7 cells are co-transfected with Caspr1 and a similar result is verified when cells are 
transfected with another deletion mutant of Caspr1, this time lacking the GNP motif of 
its intracellular C-terminal. Conversely, expression of the mutant for the proline-rich 
region, Caspr1ΔPro, resulted in GluA1 mRNA levels comparable to the control 
(unpublished data). These results further confirm the hypothesis that the upregulatory 
effect of Caspr1 in GluA1 protein and mRNA levels is specifically mediated by the 
proline-rich region of Caspr1 intracellular C-terminal tail and that this domain is 
necessary for the effect to be verified, whilst deletion of the GNP motif of Caspr1 did 
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not significantly alter the effect of Caspr1 on the GluA1 mRNA levels, indicating that 
this domain of Caspr1 is not required for its effect on GluA1 levels. 
 As previously described, Santos and colleagues proposed a role for the C-
terminal domain of Caspr1 not only in the upregulation of GluA1 levels and its 
stabilization at the cell surface, but, specifically, in its synaptic targeting (Santos, 2009). 
However, the results shown in the present study, as well as results regarding the effect 
of the deletions mutants, Caspr1ΔPro and Caspr1ΔGNP, in GluA1 mRNA levels, go 
further into understanding the molecular determinants of Caspr1 responsible for its 
effect and describe the proline-rich region of Caspr1 intracellular domain as the major 
player in the regulation of the GluA1 subunit. Given the knowledge on the architecture 
of Caspr1, particularly of its intracellular C-terminal, and of its binding partners, it is 
conceivable that Caspr1, through its proline-rich region, interacts with binding proteins 
involved in the activation of several signaling pathways that, somehow, mediate an 
upregulation in GluA1 levels. Nonetheless, despite the apparent specific requirement for 
the proline-rich region of Caspr1 in mediating its effect in the regulation of the GluA1 
subunit, it does not mean that its GNP motif is obsolete. Through interaction with 4.1 
proteins, and, indirectly, to the actin cytoskeleton, this motif of Caspr1 may promote the 
stabilization of the GluA1 subunit at the cell surface, as proposed above, and thus, 
further contribute to an overall role of Caspr1 in the regulation of the GluA1 subunit. 
Future experiments, using both deletion mutants for the proline-rich region and the GNP 
motif, should be carried to unveil, with clarity, the role that each domain of the 
intracellular C-terminal region of Caspr1 plays in this proposed regulatory mechanism 
of the GluA1 subunit, either in its mRNA and protein stability, as well as in its surface 
expression and synaptic targeting.   
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Overexpression of Caspr1 upregulates the phosphorylation of Src and of its 
downstream target, ZBP1, in cultured COS7 cells and hippocampal neurons 
 Up until now, in the present study we described an important role for the 
intracellular C-terminus of Caspr1, particularly for its proline-rich region, in the 
regulation of the GluA1 subunit of AMPARs. The evidences presented, although still 
preliminary, are extremely interesting and raise a whole set of possibilities regarding the 
mechanisms underlying the effect of Caspr1 in GluA1 levels. Contributing to this is the 
distinct structure of the intracellular C-terminal domain of Caspr1, typical of molecules 
implicated in protein-protein interactions. In particular, its proline-rich region, 
containing at least one canonical SH3 domain-binding site, is thought to interact with 
proteins involved in signaling pathways. Indeed, Peles and colleagues were able to 
selectively pull-down Caspr1 bound to SH3 domains of several signaling molecules, 
namely PLCγ, the p85 subunit of PI3K and members of the Src family of protein 
tyrosine kinases (SFK), Src and Fyn (Peles et al., 1997). All these molecules are able to 
transduce signals from the extracellular environment to intracellular biochemical 
pathways involved in controlling an array of signaling networks regulating metabolism, 
viability, proliferation, differentiation and migration, among several other physiological 
functions (Guarino, 2010; Ingley, 2008). Moreover, it was proposed that members of 
the Src family are involved in the transmission of signals generated by cell recognition 
molecules, present at the cell surface, such as L1- and N-CAM, MAG and, particularly, 
Contactin1 (Beggs et al., 1994; Ignelzi et al., 1994; Umemori et al., 1994; Zisch et al., 
1995). Being a GPI-anchored protein lacking a cytoplasmic domain, Contactin1, in 
order to mediate its biological responses, has to interact with a transmembrane protein, 
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such as Caspr1, that contains an appropriate cytoplasmic domain capable of recruiting 
and activating intracellular signaling molecules.  
Altogether, these evidences prompted us to hypothesize that, through its 
intracellular proline-rich region, Caspr1 interacts with signaling molecules that trigger 
the activation of biochemical responses that lead to the upregulation of the GluA1 
subunit. Indeed, further immunoprecipitation studies by Peles and colleagues confirmed 
an interaction between Caspr1 and Src, when both proteins were exogenously expressed 
in co-transfected COS7 cells (Peles et al., 1997). Thus, the confirmation of such a 
specific interaction between Caspr1 and Src further supports the idea of a possible 
upregulation of GluA1 levels through a Caspr1-mediated activation of Src signaling 
pathways. To confirm this hypothesis, Caspr1 was exogenously expressed in COS7 
cells, together with the GluA1 subunit. Cells were allowed to express the constructs for 
48 hrs, after which total protein levels of phosphorylated Src were assessed by western 
blot analysis (Figure 13). 
A slight increase in levels of phosphorylated Src seems to occur when Caspr1 is 
expressed in COS7 cells (Figure 13A). However, the band corresponding to phospho-
Src appears at a molecular weight of approximately 75 kDa, which is not in accordance 
to what was expected.  The monoclonal antibody used to label phospho-Src detects 
endogenous Src phosphorylated in its tyrosine residue 416 (Tyr416), located in the 
activation loop of the kinase domain of Src, which renders activity to the enzyme 
(Boggon & Eck, 2004; Thomas & Brugge, 1997). This form or Src would be expected 
to result in a protein band migrating at 60 kDa. One hypothesis to explain this 
difference in molecular weight is the occurrence of a shift in the molecular mass of Src 
after its phosphorylation and consequent activation. Also, several other posttranslational 
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modifications, such as myristoylation, palmitoylation (Koegl et al., 1994; Resh, 1999) 
etc., may be occurring at the same time of phosphorylation and thus, altogether, be 
contributing to a significant shift in the molecular weight of Src. In order to test for the 
specificity of the band observed, a dephosphorylation assay was performed in the same 
samples of Caspr1-transfected COS7 cells used before. Lysates were incubated for 2 
hrs, at 30°C, with the protein phosphatase Lambda (λPP) and levels of phosphorylated 
Src were assessed by western blot analysis, as described above (Figure 13A). As stated, 
expression of Caspr1 in COS7 cells appears to promote a slight increase in a 75 kDa 
protein, thought to correspond to phospho-Src. When the same sample was subjected to 
a dephosphorylation assay with the lambda phosphatase (GluA1 + Caspr1 + λPP), the 
75 kDa band corresponding to phosphorylated Src specifically disappeared, whilst 
labeling for Caspr1 and the human transferrin receptor (Transferrin R) remains 
distinguishable (although some proteolysis may have occurred) (Figure 13A). Hence, 
this assay suggests that expression of Caspr1 in COS7 cells results in an activation of 
Src and a consequent increase in its phosphorylated levels.  
Additionally, we further confirmed that this Caspr1-mediated activation of Src 
occurs through the intracellular proline-rich region of Caspr1 (Figure 13B and 13C). 
Expression of Caspr1 in COS7 cells does, indeed, increase the phosphorylated levels of 
Src in 36 ± 15 %, when compared to control values. The deletion mutant of Caspr1 
lacking its proline-rich region (Caspr1ΔPro), however, failed to have a similar effect, 
resulting in levels of phospho-Src to values comparable to the control (101 ± 50 % - 
Figure 13B and 13C). (Of note, this result corresponds to three independent 
experiments: in two of them levels of phospho-Src with Caspr1ΔPro were similar to 
control, whereas in the third we observed an increase in phosphorylated Src, for the 
same condition of transfection). This result is in agreement to results presented by Peles 
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and colleagues, which confirmed an interaction between Caspr1 and Src, possibly 
through the proline-rich region of Caspr1 (Peles et al., 1997). In the present study, we 
further show that this intracellular proline-rich region of Caspr1 is responsible for the 
activation of Src, since the deletion mutant for that region, Caspr1ΔPro, had no effect in 
phosphorylated levels of Src (Figure 13B and 13C). 
 
 
 
                                                                                                                                    Results & Discussion 
 
 
97 
Figure 13 – Caspr1, through its intracellular proline-rich region, is able to induce a 
specific increase in phosphorylated levels of the tyrosine kinase Src, in COS7 cells. (A) 
Cultured COS7 cells were co-transfected either with GluA1 + CMV empty vector + GFP or 
with GluA1 + Caspr1 (full-length) + GFP, as indicated. Cells were allowed to express the 
constructs for 48 hrs, after which total cell extracts were obtained. Approximately 150µg of 
protein from lysates of Caspr1-transfected cells were subjected to a dephosphorylation assay 
with lambda protein phosphatase (GluA1 + Caspr1 + λPP) for 2 hrs, at 30ºC. Levels of 
phosphorylated Src were then assessed by western blot. (B-C) Cultured COS7 cells were co-
transfected either with GluA1 + CMV empty vector + GFP, GluA1 + Caspr1 (full-length) + 
GFP or with GluA1 + Caspr1ΔPro + GFP, as indicated. Cells were allowed to express the 
constructs for 48 hrs, after which total cell extracts were obtained and levels of GluA1 and 
phosphorylated Src assessed by western blot. Results are presented as means ± S.E.M. when 
compared to control and normalized to the loading control Transferrin R (human transferrin 
receptor). Statistical analysis was determined by the one-way ANOVA analysis of variance 
followed by the Dunnett’s post test, although no statistical significance was achieved, 
p>0.05.  
 
To test for a Caspr1-mediated activation of Src in a neuronal system, Caspr1 was 
overexpressed in hippocampal neurons in culture, by transfecting high-density cultures 
at DIV7. At DIV15, total extracts were obtained and levels of phosphorylated Src were 
assessed by western blot (Figure 14A). According to the results obtained using the 
heterologous system, this preliminary result indicates that overexpression of Caspr1 in 
hippocampal neurons also appears to induce a distinct increase in the levels of phospho-
Src, when compared to the control situation (Figure 14A). This evidence in 
hippocampal neurons not only confirms the hypothesis of a role for Caspr1 in activating 
the Src signaling pathway, but also suggests an interaction between these two proteins 
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in a neuronal system, which has not been shown until now. In Src, several factors 
contribute to its inactive conformation: besides the phosphorylation on a tyrosine 
residue (Tyr527) present in the negative regulatory C-terminal tail of Src, 
intramolecular interactions between its modular SH3 and SH2 domains restrain the 
catalytic domain in such a way that phosphorylation of Tyr416, in the activating loop, is 
blocked (Boggon & Eck, 2004; Guarino, 2010; Ingley, 2008; Thomas & Brugge, 1997). 
Given our results, it is likely that the proline-rich region of Caspr1, a high affinity 
ligand of SH3 domains, competes for the SH3 domain of Src, displacing and relieving 
the intramolecular inhibition between the SH2/SH3 domains and causing a shift to the 
active form of the kinase domain of Src. Consequently, Tyr416 in the exposed 
activation loop is allowed to undergo phosphorylation, which leads to a maximal kinase 
activity, thus triggering the activation of a downstream signaling cascade. Indeed, what 
is also interesting in our results is that this Caspr1-mediated increase in phospho-Src 
appears to occur along with an increase in GluA1 levels both in COS7 cells (Figure 
13B) and in hippocampal neurons (Figure 14A), at least in the one experiment 
performed in neurons. Thus, overall, these results suggest that the upregulatory effect of 
Caspr1 in GluA1 levels may occur through a Src-dependent signaling pathway.  
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Figure 14 – Caspr1 induces an increase in total levels of phosphorylated Src, as well as a 
specific increase in the number of synaptic puncta of the phosphorylated kinase, in 
hippocampal neurons. (A) High-density cultured hippocampal neurons were transfected at 
DIV7 with GFP (Control) or with GFP + Caspr1, as indicated. Cells were allowed to express the 
proteins until DIV15, when total cell extracts were obtained and levels of GluA1 and 
phosphorylated Src assessed by western blot. (B) Primary hippocampal neurons from low-
density Banker cultures were transfected at DIV7 with GFP (Control) or with GFP + Caspr1, as 
indicated. Cells were allowed to express the proteins until DIV15, after which they were fixed 
and immunolabeled with antibodies for phosphorylated Src (red) and PSD-95 (blue). Images 
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were taken using a Zeiss Axiovert 200 fluorescent microscope. Neuronal dendrites were 
visualized via MAP2 staining and fields for imaging were chosen by the GFP channel, for the 
presence of transfected, GFP-positive, neurons. Scale bar: 20µm; Scale bar (crops): 5µm. 
Arrows indicate colocalization with PSD95 puncta (C - G) Quantification data are shown in (C-
G). Phosphorylated Src clustering was analyzed and quantified with Image J 1.43 analysis 
software. Dendrites were randomly chosen and their lengths determined. (C) The signal for total 
phospho-Src was analyzed after thresholds were set, such that recognizable clusters were 
included in the analysis, and the background intensity of each image was subtracted. (D-E) 
Synaptic (D) phospho-Src puncta were selected by colocalization with PSD-95 (see arrows), 
whereas non-synaptic (E) clusters of phospho-Src correspond to puncta that did not colocalize 
with PSD-95. (F) PSD-95 puncta were analyzed after thresholds were set, such that 
recognizable clusters were included in the analysis, and the background intensity of each image 
subtracted. (G) The percentage of synapses containing phospho-Src was determined by 
colocalization of PSD-95 puncta as a mask overlaid on the channel for phospho-Src. (C-G) Per 
each selected cell, intensity, area and number of total (C), synaptic (D) and non-synaptic (E) 
puncta of phosphorylated Src per dendritic length was determined. The same was determined 
regarding puncta of PSD-95 (F). Measurements were performed in a single independent 
neuronal preparation, with 12 cells per condition, and values obtained per cell were normalized 
against the control mean of the experiment. Results are presented as means ± S.E.M. Statistical 
analysis was determined by the unpaired t-test, (E-F) *p<0.05; ns - p>0.05. 
 
Immunocytochemistry experiments were also performed to further confirm the 
activation of Src, at the single-cell level. Low-density hippocampal neurons were 
transfected at DIV7 either with GFP (control) or GFP + Caspr1 and cells were allowed 
to express the proteins until DIV15, when they were fixed and double-labeled with 
antibodies for phosphorylated Src as well as for the postsynaptic marker PSD-95. To 
specifically evaluate the effect of Caspr1 overexpression in the activation of Src, fields 
                                                                                                                                    Results & Discussion 
 
 
103 
for imaging were chosen by the GFP channel, for the presence of transfected, GFP-
positive, neurons (Figure 14B). Surprisingly, overexpression of Caspr1 did not induce 
an increase in the intensity of total puncta of phosphorylated Src. Indeed, and contrary 
to what was observed in the western blot analysis, the total intensity of phospho-Src 
puncta is decreased in about 20% (to 79.5 ± 12 % of control), when compared to control 
values, although differences do not reach a statistical significance (Figure 14C). 
Moreover, the same effect was observed for the intensity of phosphorylated Src puncta, 
at the synaptic level (colocalized with PSD-95 – see arrows), which also decreased to 
approximately 83 ± 12 %, when compared to the control (Figure 14D). Regarding the 
area of phospho-Src puncta, comparing to control, overexpression of Caspr1 did not 
exert any differences for either total or synaptic pools. However, comparison between 
the total and synaptic number of phospho-Src puncta shows that Caspr1 induces an 
increase of about 23 % (123 ± 13 % of control) in phospho-Src puncta present at 
synapses but not in total clusters, which remain with values similar to the control 
(Figure 14C and D). Interestingly, we were able to observe that the increase in the 
number of phospho-Src puncta seems to be a specific effect on their synaptic pool. 
Overexpression of Caspr1 not only significantly decreased the intensity of non-synaptic 
phospho-Src puncta (61 ± 13 % of control, *p<0.05) and their area (74 ± 11 % of 
control, ns - p>0.05), but also had an effect in decreasing the number of non-synaptic 
puncta in about 20 % (to 80 ± 10 % of control), when compared to control values, 
although not reaching a statistical significance (Figure 14E). To further understand the 
significance of such a disparate effect in the number of synaptic and non-synaptic 
puncta of phosphorylated Src, we investigated whether Caspr1 was having an effect in 
PSD-95 puncta (Figure 14F). Indeed, overexpression of Caspr1 resulted in an increased 
intensity (113 ± 9 % of control) and area (118 ± 9 % of control) of PSD-95 puncta, as 
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well as a significant increase in their number (122 ± 8 % of control), indicating that 
there are more synapses when Caspr1 is overexpressed. This evidence is, by itself, very 
interesting, suggesting a possible role for Caspr1 in the regulation of this scaffolding 
protein. However, it compromises, in a certain way, the quantification of synaptic 
phospho-Src puncta, determined by colocalization with PSD-95 as a synaptic marker. 
Despite this, we further investigated if the totality of synapses (PSD-95 puncta per 
dendritic length) contains more phosphorylated Src, when Caspr1 is overexpressed 
(Figure 14G). Comparing with the control, there seems to be an incremental tendency in 
the percentage of synapses containing phospho-Src, when Caspr1 is overexpressed, 
although no statistical significance was attained (120 ± 9 % of control).  
Altogether, these results suggest that Caspr1 plays a role in the activation of the 
tyrosine kinase Src, increasing its phosphorylated levels. Results obtained by western 
blot analysis, both in COS7 cells and hippocampal neurons, are consistent with this 
hypothesis. On the contrary, the decrease in the intensity of total and synaptic puncta of 
phospho-Src, obtained from imaging experiments, indicates otherwise. Nevertheless, 
one must bear in mind that, while immunocytochemistry data refer to the effect of 
Caspr1 in phospho-Src exclusively in dendrites, results from western blot experiments 
are obtained from whole cell lysates, thus reflecting the contribution of cell bodies and 
axons, in which the effect of Caspr1 in the activation of Src remains unknown. It is 
possible that the major effect of Caspr1 in the phosphorylation of Src occurs at the cell 
body level, which would account for the diminished intensity of Src puncta, observed in 
the imaging experiments. Despite this, one hypothesis that arises from the increased 
number of phosphorylated Src puncta in synapses with the overexpression of Caspr1, 
which is further supported by the reduction in area and number of phospho-Src puncta 
from a non-synaptic pool, is that overexpression of Caspr1, abundant in synapses, 
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accounts for more synaptic binding sites for phosphorylated Src. Moreover, interaction 
of Src with Caspr1 may induce a fragmentation of non-synaptic puncta, leading to a 
delocalization of phosphorylated Src to more synapses, justifying the increased number 
of synaptic puncta. Thus, this would mean that more synapses would contain more 
activated Src, capable of triggering downstream signaling cascades. 
These rather interesting evidences proposing the upregulation of GluA1 levels 
by Caspr1 as well as the Caspr1-mediated activation of a signaling pathway 
downstream of Src, particularly at the synaptic level, are extremely promising. 
However, they raise one critical question. Which signaling cascade is specifically being 
triggered following the Caspr1-mediated activation of Src and which are the specific 
efectors involved in it? Src has already been thoroughly described as a regulator of 
many fundamental cellular processes including cell growth and survival, proliferation, 
cell communication, shape, differentiation and migration, among several other 
physiological functions (Huveneers & Danen, 2009; Ingley, 2008; Parsons & Parsons, 
2004; Thomas & Brugge, 1997). One of its best described and interesting roles regards 
the reorganization of the cytoskeleton, which highly impacts axonal guidance and 
neurite outgrowth in developing neurons. The downstream target of Src in these events 
is the oncofetal protein Zipcode binding protein (ZBP1). This RNA-binding protein 
binds to a conserved 54-nucleotide element, known as the ‘zipcode’, located in the 
3’UTR of β-actin mRNA (Ross et al., 1997), repressing its premature translation. Upon 
particular stimuli, Src is able to promote translation of β-actin transcripts by 
phosphorylating a key tyrosine residue in ZBP1 that is required for its binding to RNA 
(Huttelmaier et al., 2005). These sequential events provide both temporal and spatial 
control over β-actin translation and are necessary to its localization to the cell periphery. 
Particularly at developing growth cones ZBP1 activity is important for neurotrophin-
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induced neurite outgrowth (Zhang et al., 2001) and its Src-dependent phosphorylation is 
required for the assymetrical and local synthesis of β-actin and growth cone turning and 
guidance, induced by external cues such as BNDF and Netrin1 (Leung et al., 2006; 
Sasaki et al., 2010; Welshhans & Bassell, 2011; Yao et al., 2006). Apart from its role in 
axonal guidance, ZBP1 also regulates the dendritic arboring of hippocampal neurons 
(Perycz et al., 2011) and localizes to dendritic spines, regulating their density and 
structure through the local translation of β-actin (Eom et al., 2003; Tiruchinapalli et al., 
2003). Moreover, ZBP1 has also been shown to bind to the mRNA of cofilin, an actin-
depolymerizing factor, and mediate Slit2-induced local translation during growth cone 
collapse (Piper et al., 2006). Thus, it is evident that ZBP1 plays a key role in the 
regulation of some transcripts with major importance in neuronal development and 
function, which endows ZBP1 with the potential to functionally regulate other 
transcripts. 
Interestingly, a study carried out in our laboratory indicated that Caspr1 
significantly upregulates GluA1 mRNA levels in COS7 cells, and that this effect is 
specifically mediated by Caspr1 intracellular proline-rich region, since expression of the 
deletion mutant for this domain (Caspr1ΔPro) resulted in GluA1 mRNA levels 
comparable to the control (unpublished data). The new data that we are now reporting 
show that Caspr1 promotes activation of the Src signaling pathway in a proline-rich 
domain dependent manner. Given that ZBP1 is a downstream target of Src capable of 
regulating several transcripts, it would be extremely interesting to clarify if Caspr1  
affects ZBP1 as a downstream effect of the activation of Src and if so, understand if 
ZBP1 binds to GluA1 mRNA and regulates the levels of this transcript.  
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In order to evaluate if the activation of Src by Caspr1 results in a downstream 
effect in ZBP1, Caspr1 or its deletion mutant for the proline-rich region (Caspr1ΔPro) 
were exogenously expressed in COS7 cells, together with the GluA1 subunit. Cells 
were allowed to express the constructs for 48 hrs, after which total protein levels of 
phosphorylated Src, phosphorylated ZBP1 and GluA1 were assessed by western blot 
analysis (Figure 15). 
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Figure 15 – Caspr1, through its intracellular proline-rich region, induces a specific 
increase in phosphorylated levels of the Zipcode binding protein (ZBP1), in COS7 cells. 
(A-B) Cultured COS7 cells were co-transfected either with GluA1 + CMV empty vector + GFP, 
GluA1 + Caspr1 (full-length) + GFP or with GluA1 + Caspr1ΔPro + GFP, as indicated. Cells 
were allowed to express the constructs for 48 hrs, after which total cell extracts were obtained 
and levels of phosphorylated ZBP1, phosphorylated Src and GluA1 were assessed by western 
blot. Results are presented as means ± S.E.M. when compared to control and normalized to the 
loading control Transferrin R (human transferrin receptor). Statistical analysis was determined 
by the one-way ANOVA analysis of variance followed by the Dunnett’s post test, 
although no statistical significance was achieved, p>0.05. (C) Cultured COS7 cells were co-
transfected either with GluA1 + CMV empty vector + GFP or with GluA1 + Caspr1 (full-
length) + GFP, as indicated. Cells were allowed to express the constructs for 48 hrs, after which 
total cell extracts were obtained. Approximately 150µg of protein from lysates of Caspr1-
transfected cells were subjected to a dephosphorylation assay with lambda protein phosphatase 
(GluA1 + Caspr1 + λPP) for 2 hrs, at 30ºC. Levels of phosphorylated ZBP1 were then assessed 
by western blot. 
 
 In parallel to the increase in levels of phosphorylated Src (see Figure 13), 
expression of Caspr1 in COS7 cells resulted in an evident upregulation in levels of 
phosphorylated ZBP1 (227 ± 107 % of control), when compared to control (Figure 15A 
and 15B), although values do not reach statistical significance. On the other hand, 
expression of the deletion mutant of Caspr1 lacking its proline-rich domain 
(Caspr1ΔPro) resulted in a marked decrease of phospho-ZBP1 levels to control values 
(117 ± 5 % of control – Figure 15A and 15B). However, ahead of any preliminary 
conclusions, it is of notice that, similarly to what happened to phospho-Src, the 
polyclonal antibody raised against phospho-ZBP1 detected a band which mobility in 
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SDS-PAGE is compatible with a protein of 75kDa, which does not correspond to the 
65kDa expected for phospho-ZBP1. Thus, to evaluate the specificity of these results, 
lysates from Caspr1-transfected COS7 cells were subjected to a dephosphorylation 
assay with λPP, for 2 hrs at 30ºC (Figure 15C), which resulted in an almost complete 
disappearance of the 75kDa band, indicating that this band corresponds to a specific 
increase in phospho-ZBP1 by Caspr1. Overall, this upregulatory effect in phospho-
ZBP1, occurring in parallel with an increase of phospho-Src, suggests that Caspr1 is, 
indeed, activating a downstream signaling pathway of Src, which, in turn, promotes an 
increase in the phosphorylation of its target, ZBP1. Moreover, these results provide yet 
another confirmation on the major role of the intracellular proline-rich region of Caspr1, 
which is necessary for its upregulatory effect in levels of phosphorylated ZBP1. What is 
also interesting is the consistent increase in levels of phosphorylated Src and 
phosphorylated ZBP1 in parallel to an increase in GluA1 levels, in COS7 cells 
expressing Caspr1 (Figure 15A and B). Moreover, the parallel upregulation in the three 
evaluated proteins is not observed in the absence of the proline-rich region of Caspr1. 
To further confirm these results in a neuronal system, levels of phosphorylated 
ZBP1 in the presence of Caspr1 were assessed at the single cell level, by transfecting 
low-density hippocampal neurons at DIV7, either with GFP alone (control) or GFP + 
Caspr1. After expressing proteins until DIV15, cells were fixed and immunolabeled 
with antibodies for phosphorylated ZBP1 and for PSD-95 as a postsynaptic marker. To 
specifically evaluate the effect of Caspr1 in phospho-ZBP1, imaging fields were chosen 
by the GFP channel, for the presence of transfected, GFP-positive neurons (Figure 
16A). Curiously, once again, overexpression of Caspr1 did not exert the expected 
upregulatory effect in the intensity of phosphorylated ZBP1 puncta. Similarly to what 
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happened to phospho-Src, Caspr1 overexpression resulted in a significant decrease both 
in the total and synaptic intensity of phospho-ZBP1 puncta to 74 ± 4 % (***p<0.001) 
and 73 ± 4 % (***p<0.001), respectively, when compared to control values (Figure 17B 
and 16C). Moreover, the area of phospho-ZBP1 puncta, total or synaptic, seems to have 
a tendency to decrease in about 10% (approximately 91 ± 4 % of control, in both cases), 
when Caspr1 is overexpressed, although no significant difference is reached (Figure 
16B and 16C). However, the effect of Caspr1 in the number of phosphorylated ZBP1 
puncta is in opposite direction to its effect in the other analyzed parameters. Indeed, as it 
happened for the number of phospho-Src puncta, Caspr1 was able to induce not only a 
significant increase (116 ± 4 % of control, *p<0.05) in the number of total phospho-
ZBP1 puncta, but also a robust upregulation to 134 ± 7 % (***p<0.001) in the number 
of phospho-ZBP1 puncta, at the synapse level (Figure 16B and C). Furthermore, this 
increase in the number of phospho-ZBP1 puncta occurred specifically on their synaptic 
pool, since the same effect was not observed in the number of non-synaptic phospho-
ZBP1 puncta. Indeed, the number of phosphorylated ZBP1 puncta at non-synaptic sites 
remained with values similar to control, when Caspr1 was overexpressed (104 ± 5 % of 
control – Figure 16D). Also, the area of non-synaptic phospho-ZBP1 puncta was not 
altered in the presence of Caspr1, whereas their intensity was slightly decreased, 
although not to significant values (98 ± 5 % and 80 ± 5 % of control, respectively - 
Figure 16D). Additionally, an analysis on the intensity, area and number of PSD-95 
puncta was also performed in these experiments, allowing the confirmation of a possible 
role of Caspr1 in PSD-95 clustering and in the number of synapses. Once again (see 
Figure 14F), Caspr1 was able to induce a small but statistically significant increase in 
the number of PSD-95 puncta (113 ± 5 % of control), while not having any effect in the 
intensity or area of the clusters (Figure 16E). Moreover, the evaluation of the total 
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percentage of synapses (PSD-95 puncta per dendritic length) containing phosphorylated 
ZBP1 showed that, when compared to control, overexpression of Caspr1 seems to 
induce an increasing tendency in the percentage of synapses containing phosphorylated 
ZBP1 (110 ± 4 % of control), although no statistical significance was determined 
(Figure 16F). 
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Figure 16 – Caspr1 is able to induce a specific significant increase in the number of 
phosphorylated ZBP1 synaptic puncta, in hippocampal neurons. (A) Primary hippocampal 
neurons from low-density Banker cultures were transfected at DIV7 with GFP (Control) or with 
GFP + Caspr1, as indicated. Cells were allowed to express the proteins until DIV15, after which 
they were fixed and immunolabeled with antibodies for phosphorylated ZBP1 (red) and PSD-95 
(blue). Images were taken using a Zeiss Axiovert 200 fluorescent microscope. Dendrites were 
visualized via MAP2 staining and fields for imaging were chosen by the GFP channel, for the 
presence of transfected, GFP-positive, neurons. Scale bar: 20µm; Scale bar (crops): 5µm. 
Arrows represent colocalization with PSD95 puncta. (B - F) Quantification of the results shown 
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in (A). Phosphorylated ZBP1 clustering was analyzed and quantified with Image J 1.43 analysis 
software. Dendrites were randomly chosen and their lengths determined. (B) The signal for total 
phospho-ZBP1 was analyzed after thresholds were set, such that recognizable clusters were 
included in the analysis, and the background intensity of each image was subtracted. (C - D) 
Synaptic (C) phospho-ZBP1 puncta were selected by colocalization with PSD-95 (see arrows), 
whereas non-synaptic (D) clusters of phospho-ZBP1 correspond to puncta that did not 
colocalize with PSD-95. (E) PSD-95 puncta were analyzed after thresholds were set, such that 
recognizable clusters were included in the analysis, and the background intensity of each image 
subtracted. (F) The percentage of synapses containing phospho-ZBP1 was determined by 
colocalization of PSD-95 puncta as mask overlaid on the channel for phospho-ZBP1. (B-F) Per 
each selected cell, intensity, area and number of total (B), synaptic (C) and non-synaptic (D) 
puncta of phosphorylated ZBP1 per dendritic length was determined. PSD-95 clusters were also 
analysed (E). Measurements were performed in three independent experiments, with at least 16 
cells per condition, and values obtained per cell were normalized against the control mean of 
that single experiment. Results are presented as means ± S.E.M. Statistical analysis was 
determined by the unpaired t-test, (B – F) ***p<0.001; *p<0.05; ns - p>0.05. 
 
Taken together, these results tend to confirm the hypothesis of an important role 
of Caspr1 in the activation of a signaling pathway downstream of Src that results in an 
increased phosphorylation of its target ZBP1. Despite the decrease in the intensity of 
total and synaptic puncta of phospho-ZBP1, which we cannot explain, Caspr1 induces a 
specific, significant and robust increase in the number of phosphorylated ZBP1 synaptic 
puncta, an effect that does not occur in puncta present in the non-synaptic pool. A 
possible explanation for these results comes from evidences showing the presence of 
large ZBP1 granules localized to dendritic shafts and spine compartments 
(Tiruchinapalli et al., 2003). Moreover, ZBP1 colocalizes with β-actin mRNA into 
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individual dendritic RNPs or stress granules, where it promotes a transient translational 
repression of this transcript (Eom et al., 2003; Stohr et al., 2006). It is conceivable that 
ZBP1 is contained in these synaptic granules in an active, RNA-bound and 
unphosphorylated state and that, upon Src-mediated phosphorylation, granules disperse, 
promoting translation of localized transcripts. Thus, this would account for the 
increased number of phosphorylated ZBP1 synaptic puncta that results from a Caspr1-
mediated activation of the Src signaling pathway.  
 So far, together with evidences from previous studies carried out in our 
laboratory, we have seen that Caspr1 is able to not only increase total GluA1 protein 
levels, but also their surface expression and synaptic tagging [through biotinylation and 
electrophysiology experiments carried by Sandra Santos (Santos, 2009)]. Moreover, the 
increase in protein levels appears to occur through an upregulation of Caspr1 in GluA1 
mRNA levels, dependent on the proline-rich region of Caspr1 (data not shown). 
Regulation of neuronal transcripts frequently occurs through interaction of cis-acting 
elements located in their 3’UTR with specific trans-acting RNA-binding proteins. 
Indeed, analysis of the 3’UTR of GluA1, performed by Santos and colleagues, further 
indicates the presence of regulatory elements in the 3’UTR of the GluA1 transcript that 
are essential for Caspr1 to exert its effect, since Caspr1 completely lost its upregulatory 
effect in GluA1 mRNA, when the 3’UTR of GluA1 was deleted. Furthermore, a 
sequence analysis of the 3’UTR of GluA1 revealed several putative binding sites for 
RNA-binding proteins, particularly of the embryonic lethal abnormal vision (ELAV) 
family, known to regulate the stability of a subset of mRNAs (Santos, 2009). Overall, 
these evidences propose a novel way to control the GluA1 subunit, through regulation 
of its mRNA stability. If Caspr1 is regulating the stability of GluA1 mRNA levels 
through the activation of a signaling pathway downstream of Src that ends up with an 
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increase in phosphorylated levels of ZBP1, it is reasonable to propose that this 
stabilizing effect is mediated through an interaction of ZBP1, an RNA-binding protein 
that recognizes specific cis-elements in the 3’UTR of transcripts, with the mRNA of the 
GluA1 subunit. Indeed, ZBP1 has already been implicated in the regulation of stability 
of various target mRNAs, such as c-Myc, CD44, βTrCP1 and β-catenin (Gu et al., 2008; 
Leeds et al., 1997; Noubissi et al., 2006; Vikesaa et al., 2006; Yisraeli, 2005). Future 
experiments should be carried out to confirm a possible interaction between ZBP1 and 
the GluA1 mRNA and to evaluate a possible regulation of the stability of GluA1 
transcripts by this RNA-binding protein.  
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Chronic blockade of neuronal activity increases levels of endogenous Caspr1 
 Given the physiological importance of AMPA receptors, comprehending how 
dendritic transcripts of the GluA1 subunit are regulated would provide further insight 
into the mechanisms underlying synaptic plasticity. So far, we have seen that the new 
interactor of the GluA1 subunit, Caspr1, may play a major role in the regulation of 
GluA1 protein, and particularly of its mRNA stability. Moreover, we proposed that this 
effect occurs through a Caspr1-mediated activation of a Src signaling pathway that ends 
up in the phosphorylation of the downstream target ZBP1, a RNA-binding protein that 
could stabilize GluA1 transcripts. Thus, since Caspr1 is the most upstream effector in 
this mechanism, it would be important to understand which physiological stimuli 
regulate endogenous Caspr1, and in particular to test if it is regulated by neuronal 
activity.  
 The information available about the regulation of Caspr1 concerns its 
intracellular traffic. Apparently, the interaction between Contactin1 and Caspr1 is 
essential for its expression at the cell surface. This interaction occurs at the ER and it is 
required for an efficient recruitment of Caspr1 to lipid rafts and sorting to the plasma 
membrane (Boyle et al., 2001; Faivre-Sarrailh et al., 2000). Moreover, expression of 
Caspr1 on its own, in neuroblatoma cells, resulted in its ER retention, a phenomenon 
that seems to be dependent on an ER retention signal located in the extracellular PGY-
repeat region of Caspr1 (Bonnon et al., 2007; Bonnon et al., 2003). Further evidences 
regarding the control of endogenous Caspr1 in neurons, particularly in what concerns its 
synaptic function, have not been described so far, although Caspr1 has been described 
to localize to postsynaptic regions (Murai et al., 2002). 
Chapter 3                                                                                                                   
 
118 
 In an attempt to uncover mechanisms that regulate the endogenous levels of 
Caspr1, we decided to evaluate physiological stimuli that exert an effect in the GluA1 
subunit of AMPARs similar to the effect we have observed when we overexpress 
Caspr1, that is an upregulation of the GluA1 protein levels. Neurons use homeostatic 
mechanisms to elicit changes in the strength of excitatory synapses in response to 
prolonged increases or decreases in activity (Turrigiano & Nelson, 2000). Indeed, 
accumulating evidences from recent years indicate that manipulations that chronically 
affect neuronal activity have a major impact on the total levels of GluA1 and 
particularly in the subunit content in synapses (O'Brien et al., 1998; Wierenga et al., 
2005). This synaptic scaling, through changes in AMPAR accumulation, comprises one 
form of homeostatic plasticity, which adjusts the overall synaptic strength of a neuron to 
compensate for unrestrained changes in activity that would saturate synapses and take 
them out of the physiological range of neuronal activation (Turrigiano, 2008). 
Accordingly, Ju and colleagues showed that the chronic blockade of synaptic activity in 
hippocampal neurons, either with TTX (blocker of voltage-gated sodium channels) or 
APV (selective antagonist of NMDA receptors) for 3 days, resulted in a selective 
enhancement of the dendritic synthesis of the GluA1 subunit, presumably to increase 
GluA1 levels and compensate for the lack of activity (Ju et al., 2004). Conversely, 
Turrigiano and colleagues showed that, in cortical neurons, blocking GABA-mediated 
inhibition with bicuculline decreased the amplitude of mESPCs, possibly through a 
postsynaptic change in glutamate responsiveness or a presynaptic change in the 
glutamate content of synaptic vesicles (Turrigiano et al., 1998). 
Despite the evidences regarding the cellular properties of homeostatic plasticity, 
the molecular mechanisms underlying this negative feedback by which synaptic 
strength is adjusted are still poorly understood. Nevertheless, novel players, whose loss 
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of function interferes with the expression of homeostatic plasticity, have been identified 
and contribute to emphasize the complexity of possible signaling pathways that neurons 
use to maintain their homeostasis (Pozo & Goda, 2010). One of the first identified 
players was the immediate-early gene Arc/Arg3.1 that is rapidly induced by neuronal 
activity and mediates homeostatic synaptic scaling of AMPARs via its ability to activate 
a novel and selective AMPAR endocytic pathway (Shepherd et al., 2006). Also, a recent 
study showed a specific postsynaptic requirement for β3 integrins in scaling up of 
synaptic AMPARs induced by activity suppression: under basal condition, β3 integrins 
act to stabilize synaptic AMPARs and loss of function of these cell adhesion molecules 
specifically impaired the homeostatic scaling up of mEPSCs mediated by a TTX-
induced blockade of activity (Cingolani et al., 2008). The β3-mediated homeostatic 
scaling suggests an important contribution of the extracellular matrix and surrounding 
environment in the coordination of homeostatic changes. Furthermore, in another study, 
TNFα, a pro-inflammatory cytokine produced in glial cells, was implicated in 
homeostatic synaptic scaling through upregulation of the cell surface expression of 
AMPARs and their synaptic insertion upon pharmacological blockade of neuronal 
activity in hippocampal neurons with TTX, leading to a compensatory increase in 
AMPAR-mediated currents (Stellwagen & Malenka, 2006). These evidences confirm an 
active participation of the extracellular environment, particularly of glial cells, in the 
homeostatic activity-dependent regulation of synaptic connectivity (Stellwagen & 
Malenka, 2006). Interestingly, besides exerting an effect in the GluA1 subunit similar to 
that of TNF-α, Caspr1, complexed with Contactin1, localizes to the cell membrane and 
interacts with RPTPβ (receptor protein tyrosine phosphatase β) expressed on the surface 
of glial cells. This interaction allows for the bidirectional exchange of signals between 
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glia and neurons and contributes to the homeostasis between them and their local 
environment (Peles et al., 1997).  
 Thus, to evaluate if chronic changes in neuronal activity can regulate the 
endogenous levels of Caspr1, activity in hippocampal neurons was bidirectionally 
manipulated. Hippocampal neurons at DIV14 were stimulated for 24 hrs, at 37ºC with 
TTX or bicuculline (Bicc), to either block or enhance, respectively, neuronal activity. 
After 24 hrs, cell lysates were obtained and levels of GluA1 and Caspr1 were assessed 
by western blot (Figure 17). 
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Figure 17 – TTX-induced blockade of activity increases both GluA1 subunit and Caspr1 
total levels in cultured hippocampal neurons. (A) High-density cultured hippocampal 
neurons at DIV14 were treated for 24 hrs, at 37ºC, either with Tetrodotoxin (TTX) 1μM or with 
Bicuculline (Bicc) 40μM, as indicated. After this period, total GluA1 (B) and Caspr1 (C) levels 
were assessed by western blot and quantified. (B – C) Results are presented as means ± S.E.M. 
when compared to control and normalized to the loading control GAPDH. Statistical 
significance was determined by One-Way ANOVA followed by the Dunnett’s Multiple 
Comparison post-test. (B – C) *p<0.05; ns - p>0.05. 
  
 As expected, chronic blockade of activity induced by a 24 hrs-treatment of 
hippocampal neurons with TTX, resulted in a significant increase of 111% (to 211 ± 90 
% of control, *p<0.05) in total levels of the GluA1 subunit (Figure 17B), in agreement 
with previous reports (O’Brien et al., 1998; Wierenga et al., 2005). This result indicates 
that stimulating hippocampal neurons for 24 hrs with TTX at a concentration of 1µM is 
enough to chronically block activity and induce mechanisms of homeostatic plasticity 
that result in synaptic scaling of GluA1 levels. Conversely, the chronic enhancement of 
neuronal activity with bicuculline did not result in a decrease of total GluA1 levels, as 
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would be expected. Instead, bicuculline promoted a slight but not significant increase in 
GluA1, when compared to control levels (140 ± 38 % of control) (Figure 17B).  It is 
unclear at this point why bicuculline did not exert the expected effect in regulating the 
levels of GluA1 upon enhancement of activity, as previously reported (Turrigiano et al., 
1998). Either bicuculline is not exerting its effect in the blockade of GABA receptors or 
its effect is occluded by a contribution from the vehicle (DMSO). More experiments 
should be performed using DMSO as a control for bicuculline, in order to exclude a 
possible contribution from the vehicle.  
 With an established protocol to induce homeostatic mechanisms in hippocampal 
neurons that results in the synaptic scaling of GluA1, we could now test if this type of 
physiological stimuli has an effect in the regulation of endogenous levels of Caspr1. 
Indeed, when hippocampal neurons were stimulated with TTX for 24 hrs to chronically 
block activity, levels of endogenous Caspr1 increased significantly to 141 ± 37 % 
(*p<0.05), when compared to control values (Figure 17C). When neurons were treated 
with bicuculline, levels of Caspr1 were very similar to the control (107 ± 8 % of 
control). The changes in Caspr1, induced by chronic blockade of neuronal activity were 
also confirmed by imaging experiments. Hippocampal neurons at DIV20 were 
stimulated with TTX for 24 hrs, at 37ºC, to chronically block neuronal activity. After 24 
hrs, cells were fixed and immunolabeled with antibodies against Caspr1 and the 
synaptic marker PSD-95 (Figure 18). 
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Figure 18 – Caspr1 is significantly increased in hippocampal neurons where activity has 
been chronically blocked with TTX. Primary hippocampal neurons from low-density Banker 
cultures were stimulated at DIV20 with TTX 1µM for 24 hours, at 37ºC, in order to chronically 
block neuronal activity. After the period of stimulus, cells were fixed and immunolabeled with 
antibodies for Caspr1 (red) and PSD-95 (green) as a postsynaptic marker. Images were taken 
using a Zeiss Axiovert 200 fluorescent microscope. Fields for imaging were chosen by the 
MAP2 channel. Images were obtained using identical settings.  Scale Bar: 20µm. Scale Bar 
(crops): 5µm. Arrows represent colocalization with PSD95 puncta.  
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 These representative images clearly show that chronic stimulation of 
hippocampal neurons with TTX induces a major upregulation in levels of endogenous 
Caspr1. Moreover, it also appears that this stimulus promotes an increase, at least in 
number, in clusters of Caspr1 at the synaptic level, which can be evaluated by the 
increase in colocalization with PSD-95 puncta (see arrows - Figure 18). Quantitative 
analysis of this effect should now be performed. 
Altogether, these evidences indicate that chronic blockade of neuronal activity 
induced by TTX not only increases GluA1 levels but also the expression of Caspr1, thus 
allowing the identification of a novel physiological stimulus regulating the endogenous 
levels of Caspr1. Moreover, if we correlate the synaptic scaling of the GluA1 subunit, 
which occurs upon induction of homeostatic changes, with our results concerning the 
overall effect of Caspr1, we can pinpoint a possible role for the Caspr1-mediated 
upregulation of GluA1 mRNA in the mechanisms underlying homeostatic plasticity. 
Interestingly, a similar description of regulation and function has been proposed for 
retinoic acid (RA). In a recent study, synaptic scaling in hippocampal neurons induced 
by activity blockade with TTX and APV also resulted in an increased RA synthesis 
(Aoto et al., 2008). Moreover, exogenous application of RA promoted a rapid scale up 
of AMPARs that occluded the same effect induced by TTX and APV. Furthermore, the 
synaptic scaling induced by RA occurred through the local synthesis of GluA1, through 
signaling via the RA receptor, RARα, which is dendritically localized (Aoto et al., 
2008; Maghsoodi et al., 2008). Overall, these evidences propose a possible role for 
Caspr1 in mediating GluA1 synaptic scaling upon homeostatic changes, and further 
suggest a role for dendritic protein synthesis in the onset of homeostatic plasticity. 
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Chronic blockade of neuronal activity increases levels of phosphorylated Src and 
phosphorylated ZBP1 
 Summarizing what was described so far, we have seen that Caspr1 is able to 
promote an increase in total levels of the GluA1 subunit of AMPARs, both in COS7 
cells and in hippocampal neurons. Also, this effect seems to require the intracellular 
proline-rich region of Caspr1, since Caspr1 lacking this domain fails to upregulate 
GluA1. Moreover, preliminary results obtained in our laboratory further confirm the 
role of proline-rich region of Caspr1 in mediating its effect in the upregulation of 
GluA1, particularly at the mRNA level. This region is highly implicated in protein-
protein interaction, which prompted the hypothesis that Caspr1 would be exerting its 
effect through activation of some signaling pathway, via the proline-rich region. In 
agreement with previous evidence suggesting a possible interaction between the 
tyrosine kinase Src and the proline domain of Caspr1, we found that Caspr1, 
particularly at the synaptic level, activates a signaling pathway downstream of Src, 
which involves the RNA-binding protein ZBP1. This signaling pathway culminates in 
the Src-mediated phosphorylation of ZBP1 and loss of its RNA-binding activity. 
Correlation of all these results raises the hypothesis of a mechanism in which ZBP1 
binds GluA1 mRNA. Upon Caspr1-mediated activation of the downstream pathway of 
Src, ZBP1 is phosphorylated and GluA1 mRNA molecules are free to be locally 
translated at synaptic sites.  
 This rationale is consistent with the homeostatic synaptic scaling of GluA1 that 
occurs in response to chronic changes in activity. Accordingly, we have already 
proposed a role for the Caspr1-mediated upregulation of GluA1 mRNA in the 
mechanisms that underlie homeostatic plasticity, since chronic blockade of activity with 
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TTX resulted in an increase of endogenous Caspr1. Thus, it would be interesting to 
evaluate if such a manipulation of neuronal activity induces an activation of the Src 
signaling pathway that parallels that of Caspr1. 
 To achieve this goal, hippocampal neurons at DIV14 were stimulated for 24 hrs 
with TTX to chronically block activity. After this period, cell lysates were obtained and 
levels of phosphorylated Src and phosphorylated ZBP1 were assessed by western blot 
(Figure 10). Moreover, to assess the specificity of the results, lysates from hippocampal 
neurons treated with TTX were subjected to a dephosphorylation assay with the 
Lambda protein phosphatase (Figure 19A and 19C). In both control and TTX-
stimulated conditions, labeling either with an antibody for phospho-Src (A) or phospho-
ZBP1 (C) detects bands of approximately 75kDa, previously identified in Caspr1-
transfected lysates as corresponding either to phospho-Src (Figure 13A) or phospho-
ZBP1 (Figure 15C). These bands specifically disappear when samples are 
dephosphorylated with λPP (A and C – TTX 1µM + λPP), which ensures the specificity 
of the results further presented.  
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Figure 19 – Chronic blockade of activity, induced by TTX, results in an increase of total 
levels of phosphorylated Src and phosphorylated ZBP1, in cultured hippocampal neurons. 
(A, C-D) Primary high-density hippocampal neurons at DIV14 were treated for 24 hrs, at 37ºC, 
with Tetrodotoxin (TTX) 1μM, as indicated. After this period, whole cells lysates were 
obtained. Approximately 150µg of protein from TTX-stimulated lysates were subjected to a 
dephosphorylation assay with lambda protein phosphatase (TTX 1µM + λPP) for 2 hrs, at 30ºC. 
Levels of total Src and of its phosphorylated counterpart (A - B) and phosphorylated ZBP1 (C - 
E) were assessed by western blot and quantified. (B, E) Results are presented as means ± S.E.M. 
when compared to control and normalized to the loading control β-Tubulin. Statistical analysis 
was determined by the unpaired t-test, although no statistical significance was achieved, p>0.05. 
 
 Interestingly, when neuronal activity in hippocampal neurons was chronically 
blocked for 24 hrs with TTX, levels of phosphorylated Src suffered a major increase to 
181 ± 34 %, when compared to control values (Figure 19A and B). A similar effect was 
observed for the levels of phosphorylated ZBP1 (Figure 19D and E). TTX-induced 
blockade of activity resulted in a marked increase of about 120 % (220 ± 60 % of 
control) in levels of phosphorylated ZBP1, when compared to the control situation. 
Overall, TTX-induced chronic blockade of activity appears to play a role in the 
activation of the Src signaling pathway, increasing levels of its phosphorylated 
counterpart as well as of its downstream target, phospho-ZBP1.  
 These evidences correlate to the upregulatory effect that TTX-induced blockade 
of activity has in synaptic scaling of GluA1 and expression of Caspr1. And altogether, 
they further contribute to the tantalizing hypothesis of a Caspr1-mediated upregulation 
of GluA1 mRNA that may play a role for the induction of a form of synaptic scaling 
that requires dendritic protein synthesis (Sutton et al., 2006). Just recently, the FMRP 
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RNA-binding protein has been implicated in mechanisms underlying homeostatic 
plasticity. By binding to target mRNAs, FMRP is thought to act as a downstream 
mediator of RA-signaling, crucial for the dendritic protein synthesis triggered by this 
signaling molecule, unveiling a novel role for FMRP in the induction of homeostatic 
plasticity. All evidences taken into account, it is reasonable to propose that upon chronic 
changes in activity the expression of endogenous Caspr1 is increased. In turn, Caspr1 
mediates the activation of a signaling pathway downstream of Src that culminates in the 
phosphorylation of ZBP1. This event promotes the release of ZBP1 target mRNAs, 
creating an on-site pool of transcripts ready to undergo translation. It is possible that 
ZBP1 interacts with GluA1 transcripts. ZBP1 is a RNA-binding protein that recognizes 
specific ‘zipcodes’ located in the 3’UTR of its target mRNAs. Conversely, the 3’UTR 
of GluA1 is thought to contain not only endogenous regulatory elements, but also 
multiple putative binding sites for trans-acting proteins. If so, the Src-dependent 
phosphorylation of ZBP1, as a downstream consequence of higher Caspr1 expression, 
will contribute to increase the availability of GluA1 transcripts on-site. This will 
increase the synthesis of novel AMPARs and their synaptic insertion and ultimately 
contribute to the homeostatic synaptic scaling that counteracts massive changes in 
activity. 
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Conclusion 
 Recent data from our laboratory identified the integral membrane protein 
Contactin associated protein1 (Caspr1) as a novel interactor of the GluA1 subunit, 
capable of upregulating the expression of this AMPAR subunit, particularly at the 
mRNA level. This evidence suggested a novel post-transcriptional regulatory 
mechanism for AMPARs that could be of crucial importance to the induction of 
mechanisms underlying several forms of synaptic plasticity. This possibility prompted 
us to further characterize the regulation of the GluA1 subunit by Caspr1.  
 Firstly, we aimed at characterizing the role of Caspr1 in the total protein levels 
of the GluA1 subunit and found that, both in a heterologous system and in hippocampal 
neurons, protein levels of GluA1 are significantly increased when Caspr1 is 
overexpressed (Figure 10). Moreover, we were able to map the molecular determinant 
of Caspr1 responsible for its effect in GluA1 levels. A Caspr1 mutant specifically 
deleted for its intracellular proline-rich domain failed to increase GluA1 levels (Figure 
12), which pinpoints a specific requirement for this region in the upregulatory effect that 
Caspr1 exerts. Taken together, these results are consistent with previous evidences by 
Sandra Santos proposing a major role for the C-terminal of Caspr1 not only in the 
upregulation of GluA1 levels and its stabilization at the cell surface, but specifically, in 
its synaptic targeting (Santos, 2009).  
 Secondly, we sought to identify and characterize the molecular mechanisms 
underlying the effect of Caspr1 in GluA1 levels. With the proline-rich region of Caspr1 
identified as the major player in this effect, it was reasonable to consider that the effect 
of Caspr1 would occur through triggering of some signaling pathway, since the proline 
region of Caspr1 had previously been described to interact with SH3 domains of several 
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signaling molecules, particularly with that of the tyrosine kinase Src (Peles et al., 1997). 
This led us to hypothesize that the effect in GluA1 levels would be mediated by Caspr1-
dependent activation of the Src signaling cascade and, indeed, we were able to confirm 
this hypothesis. Expression of Caspr1 in COS7 cells resulted not only in increased 
levels of phosphorylated Src (Figure 13), but also of phosphorylated ZBP1 (Figure 15), 
a downstream target of Src. Moreover, in hippocampal neurons, Caspr1 induced a 
significant increase in the number of both phosphorylated Src and ZBP1 puncta, 
specifically at the synaptic level (Figures 14 and 16). Also, this Caspr1-mediated 
increase in phospho-Src and phospho-ZBP1 paralleled that of GluA1, and all three 
effects were absent when the proline domain was deleted from Caspr1. These evidences 
could point to a role for ZBP1 in mediating the upregulation of GluA1. ZBP1 is a RNA-
binding protein known to regulate mRNA translation upon Src-dependent 
phosphorylation, by binding to specific zipcodes located in the 3’UTR of its target 
mRNAs (Huttelmaier et al., 2005; Ross et al., 1997). Moreover, ZBP1 has already been 
described to localize to dendritic RNPs and stress granules where it promotes the 
stabilization of several transcripts (Gu et al., 2008; Leeds et al., 1997; Noubissi et al., 
2006; Stohr et al., 2006; Vikesaa et al., 2006). Accordingly, evidences from our 
laboratory indicate not only, the presence of several regulatory cis-elements located in 
the 3’UTR of GluA1 mRNA that are required for the upregulatory effect of Caspr1, but 
also several putative binding sites for RNA-binding proteins. These evidences, thus 
suggest the possibility a post-transcriptional regulation of GluA1 at the level of mRNA 
stability, mediated by binding of ZBP1 to GluA1 transcripts.  
 Finally, given the importance of dendritically localized GluA1 transcripts to the 
expression of synaptic plasticity and the role that Caspr1 may exert in these 
mechanisms, we tried to investigate how the endogenous expression of Caspr1 is 
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regulated by neuronal activity. Interestingly, the effect of Caspr1 in GluA1 levels 
parallels that of chronically blocking neuronal activity, which results in the expression 
of homeostatic plasticity mechanisms, such as the synaptic scaling of AMPARs, 
increasing GluA1 dendritic synthesis and accumulation at synapses (Turrigiano, 2008). 
Accordingly, when chronically blocking neuronal activity with TTX we observed not 
only a significant increase in GluA1 levels, but also a significant increase in total levels 
of endogenous Caspr1 (Figure 17 and 18), which suggests that upon changes in 
neuronal activity the expression of Caspr1 is altered, consequently inducing 
upregulatory mechanisms in GluA1 levels that contribute to AMPAR synaptic scaling 
and expression of homeostatic plasticity. Moreover, this manipulation of neuronal 
activity also resulted in the activation of the Src signaling pathway, since chronic 
blockade of activity resulted in increased levels for both phosphorylated Src and ZBP1 
(Figure 19). Altogether, these evidences propose a possible Caspr1-mediated 
mechanism that leads to the upregulation of GluA1 mRNA, through activation of Src 
signaling cascade, and suggest that this mechanism is induced by chronic activity 
blockade. 
 Based on the current knowledge and on the evidences in this study, our current 
hypothesis is that after transcription ZBP1 binds to cis-elements located in the 3’UTR of 
GluA1 transcripts, incorporating them in ribonucleoproteins that localize to specific 
dendritic sites, exerting a stabilizing effect in GluA1 mRNA. Upon chronic changes in 
activity the expression of Caspr1 is upregulated. In turn, Caspr1 interacts, through its 
proline-rich region, with the tyrosine kinase Src, rendering it active and triggering its 
downstream signaling pathway that culminates in the phosphorylation of ZBP1. This 
event promotes the release of the GluA1 mRNA from its binding to ZBP1, thus creating 
an on-site pool of GluA1 transcripts ready to undergo translation. This will then 
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increase local synthesis of novel AMPARs and promote their synaptic insertion, 
contributing to the expression of homeostatic synaptic scaling that, ultimately, 
counteracts the initial change in activity.  
 Overall, with this study we were able to highlight a possible post-transcriptional 
role for Caspr1, involving the RNA-binding protein ZBP1, in the regulation of the 
GluA1 subunit of AMPARs. Post-transcriptional gene regulation, including regulation 
of mRNA translation and stability, has gained a significant amount of attention in these 
last years and is now regarded as a major mechanism to regulate eukaryotic gene 
expression. Particularly in the CNS, this level of regulation appears to have a critical 
role in mediating events that underlie the phenomena of synaptic plasticity. Alterations 
in the accumulation of AMPARs at synapses are critical to induce long-term changes in 
the strength and efficacy of glutamatergic synapses. Thus, regulation of AMPARs at a 
post-transcriptional level could be of major importance in altering synaptic AMPAR 
composition and number, ultimately underlying the expression of synaptic plasticity 
mechanisms. Moreover, this type of regulation at the mRNA level must be crucial to the 
induction of homeostatic mechanisms that rely on dendritic protein synthesis, such as 
the synaptic scaling of AMPARs. Accordingly, based in the present study we propose 
that the Caspr1-mediated post-transcriptional regulation of GluA1 may contribute to the 
expression of mechanisms in the basis of homeostatic plasticity.  
 Nevertheless, future work will be necessary to elucidate the role of Caspr1 in 
regulating GluA1 mRNA, possibly through a stabilizing mechanism, and further 
comprehend how this level of post-transcriptional regulation of AMPARs impacts the 
onset of homeostatic plasticity. 
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Future perspectives 
 In this work, together with previous evidences obtained in our laboratory, we 
have demonstrated that Caspr1 induces an upregulatory effect in the GluA1 subunit of 
AMPARs. We have shown that Caspr1, through its proline-rich domain, is able to 
induce an increase both in protein (present study) and mRNA (Luís Ribeiro and Sandra 
Santos, personal communication) levels of GluA1, possibly through a stabilizing effect 
in transcripts for GluA1. Nevertheless, further studies are required in order to 
understand the mechanisms underlying this effect. 
 Firstly, one of the essential milestones that needs to be achieved in the future to 
fully understand the regulation of the GluA1 subunit by Caspr1 is to determine how 
Caspr1 affects the stability of GluA1 transcripts, possibly by regulating their 
degradation or translation rate. This could be tested by evaluating levels of GluA1 
mRNA, in the presence or absence of Caspr1, at several time points after the application 
of the transcription inhibitor actinomycin D. Moreover, using the same approach in 
hippocampal neurons transduced with lentivirus to either overexpress Caspr1 or silence 
its expression with specific shRNAs for Caspr1, would allow us to determine the 
physiological role of endogenous Caspr1 in regulating the half-life of GluA1 mRNA. 
 Moreover, given the role of dendritically localized GluA1 mRNA in 
mechanisms of synaptic plasticity, and the localization of Caspr1 to dendrites and 
postsynaptic densities, we could assess the importance of Caspr1 in regulating dendritic 
GluA1 mRNA by overexpressing or knocking down the expression of endogenous 
Caspr1 in hippocampal neurons grown on filters through which axons and dendrites, but 
not cell bodies, can penetrate (Manadas et al., 2009), and compare the GluA1 mRNA 
harvested from the different subcellular compartments.  Another approach to confirm 
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the role of Caspr1 in the regulation of dendritic GluA1 transcripts would be to 
specifically evaluate GluA1 mRNA exclusively in isolated dendrites of neurons where 
Caspr1 had been overexpressed or silenced by performing fluorescence in situ 
hybridization assays using oligonucleotide probes for GluA1.  
 In this study we have also shown that the overexpression of Caspr1 induces the 
activation of a downstream signaling cascade of Src that culminates in the 
phosphorylation of ZBP1, a RNA-binding protein known to bind to the 3’UTR of 
several transcripts to regulate their stability and translation. This would point to a 
possible role for ZBP1 in regulating the mechanisms activated by Caspr1 that induce a 
stabilization of GluA1 mRNA. Thus, it would be interesting to search for putative 
binding sites for ZBP1 in GluA1 mRNA and use biotinylated RNA oligonucleotides 
corresponding to these sequences, or the full length 3’UTR of GluA1, to test for the 
pulldown of ZBP1. Also, immunoprecipitation of ZBP1 or non-radioactive 
electrophoretic mobility shift assays, using probes against the zipcodes found in GluA1 
mRNA could be performed to evaluate bound GluA1 mRNA or ZBP1, respectively. 
Furthermore, we could also evaluate the half-life of GluA1 mRNA, following 
transcription inhibition with actinomycin D, in hippocampal neurons where the 
expression of ZBP1 is silenced with RNA interference. These experiments would be 
crucial to confirm the interaction between both ZBP1 and GluA1 mRNA and unravel a 
ZBP1-dependent regulation of GluA1 mRNA stability. Moreover, to further confirm the 
importance of the Caspr1-activated Src signaling pathway and Src-dependent 
phosphorylation of ZBP1 in the upregulation of GluA1 levels we could measure total 
and synaptic levels of GluA1 in neurons overexpressing Caspr1 but treated with a 
specific inhibitor of Src, which we would expect to block the increase in GluA1 levels 
seen with Caspr1 overexpression. 
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 Furthermore, in the present work we were also able to observe that chronic 
blockade of neuronal activity, a manipulation known to induce the expression of 
homeostatic plasticity mechanisms, resulted not only in increased levels of GluA1, but 
also of Caspr1, phosphorylated Src and phosphorylated ZBP1, suggesting a role for the 
Caspr1-mediated upregulation of GluA1, possibly through activation of the Src 
pathway, in the induction of homeostatic mechanisms, such as the synaptic scaling of 
AMPARs. Thus, it would be interesting to confirm that Caspr1 plays an important role 
in the induction of these homeostatic mechanisms. If so, it is expectable that knocking 
down the expression of endogenous Caspr1 blocks the synaptic scaling of GluA1 levels 
induced by chronic blockade of activity, whereas Caspr1 overexpression occludes this 
effect. If confirmed, these effects would support the idea that a Caspr1-dependent 
mechanism is necessary for the induction of AMPARs synaptic scaling. Also, if by 
blocking the activation of Src pathway, with a specific Src inhibitor, or knocking down 
the expression of ZBP1 we would block the effect of chronic blockade of neuronal 
activity in GluA1 levels, we would further confirm that the Src signaling pathway 
possibly mediates the effect of Caspr1 in these homeostatic mechanisms. Most 
importantly, we would contribute with knowledge to the possibility of a form of 
homeostatic synaptic scaling that is dependent on post-transcriptional mechanisms to 
regulate availability and local dendritic protein synthesis of transcripts important to 
synaptic plasticity.  
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